Ovarian function in dairy cattle after gonadotropin-releasing hormone treatments during perioestrus by Taponen, Juhani
Department of Clinical Veterinary Sciences
Faculty of Veterinary Medicine
University of Helsinki
Finland
Ovarian function in dairy cattle
after gonadotropin-releasing hormone treatments
during perioestrus
by
Juhani Taponen
ACADEMIC DISSERTATION
To be presented, with the permission of
the Faculty of Veterinary Medicine, University of Helsinki,
for public criticism
in Auditorium Maximum, Hämeentie 57, Helsinki,
on August 29th, 2003, at 12 noon.
HELSINKI 2003
kirjavalmis5.pmd 2.7.2003, 10:093
ISBN 952-91-6142-5 (paperback) 
ISBN 952-10-1298-6 (PDF) 
 
Helsinki 2003 
Yliopistopaino 
   Hedelmättömyys.
   Usein kuulee eläinten omistajain valittavan sitä, että
on vaikea saada eläimiä tiineiksi. Toisinaan ilmautuu
hedelmättömyys liiallisen, toisinaan vähentyneen
siitoshimon ohella. Hedelmättömyys riippuu välistä
myös koiraksien kykenemättömyydestä. Mutta tavalli-
sesti tulee se siitä, että naaras-eläin on liian lihava tahi
sen siitos-elimet virheellisiä.
   Liiallisen siitoshimon vähentämiseksi käytettäköön
kanverttiä, 4 – 6 grammaa kahdesti päivään ja useampi-
en päivien kuluessa. Liian laimeaa himoa voidaan jos-
kus virkistää Espanjan kärpäsillä, mutta nämä ovat
myrkyllisiä ja sentähden vaarallisia käyttää. Suonen-
isku vähää ennen astuttamista vaikuttaa toisinaan edulli-
sesti lihaviin eläimiin. Jos hedelmättömyyden syynä on
epämuodostuksia naaraksen siitos-elimissä, tulee käyt-
tää eläinlääkärin apua.
Kirjasta Suomen maataloudessa käy-
tettävien kotieläinten taudit, toim.
läänineläinlääkäri O.V. Löfman, G.L.
Söderström 1896
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ABSTRACT
In tie-stall conditions, especially during the long wintertime in Finland and in
other northern countries, oestrus detection is difficult because of the common
occurrence of silent oestrus. It may be very difficult to decide when to call the
artificial insemination (AI) technician to inseminate the cow. Because of this,
gonadotropin-releasing hormone or its agonists (GnRH) are often used by
practitioners to induce ovulation close enough to insemination in hope of
improving the pregnancy rate. Under these circumstances, GnRH may be given
even as long as one or two days before, or even after the physiological luteinising
hormone (LH) surge.
Although the effect of GnRH treatment given at the time of AI on pregnancy rate
has been mainly positive, several trials have shown lower pregnancy rates in
treated animals than in control animals. Although the decrease has generally been
small, two studies have shown a significant negative effect of GnRH on
pregnancy rate. GnRH treatment in combination with induction of oestrus using
prostaglandin F2α or its agonists (PG) have shown some evidence of possible
negative effects of GnRH on subsequent luteal function or fertility. In addition,
some studies have shown a negative effect of GnRH when given during
metoestrus.
The overall aim of the present study was to find and characterise possible
negative effects of GnRH treatments given during perioestrus on reproductive
functions, with special focus on the prostaglandin-induced oestrus period and
effects on the ovulatory follicle, ovulation, subsequent follicular growth, and
luteal function.
The first experiment studied the influence of exogenous GnRH (gonadorelin)
given before the expected physiological LH surge on oestradiol secretion of the
ovulatory follicle, on occurrence of ovulation, development and function of the
corpus luteum (CL) and growth of a dominant follicle after ovulation. Six heifers
and three cows were assigned once to each of the following treatment or control
manipulations, receiving either a single dose (100 µg) of gonadorelin at 24 h, 48
h, or 72 h after PG, or no gonadorelin (control). In two animals, when GnRH was
given 24 hours after PG, luteolysis took place on day 5 or 6 after ovulation, and
animals ovulated on day 9 or 10. It is suggested that early induction of ovulation
with GnRH can cause shortened luteal function in cattle and, ultimately, reduced
fertility.
6
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The influence of exogenous GnRH given shortly post-ovulation on the
development and function of the CL and the length of the subsequent oestrous
cycle was studied in six heifers and three cows. The oestrous cycles were
synchronised using PG. After detection of ovulation, one of the following
treatments was administered: gonadorelin (250 µg) at either 0-24 hours or 24-48
hours post-ovulation, or no gonadorelin (control). Every animal was assigned
once to each of these three manipulations. GnRH treatment during metoestrus did
not seem to alter subsequent luteal function, thus failing to confirm previous
reports of reduced fertility post-treatment.
To confirm earlier findings, obtained with a small number of animals, that GnRH
can shorten CL functional life when it is administered 24 h after PG treatments
given 7 to 9 days after oestrus, sixty lactating commercial dairy cows were
selected. In addition, the effects of two treatments, PG alone or PG plus GnRH
given before mid-dioestrus, on signs of oestrus were studied. Eight days after
spontaneous oestrus, animals were given PG. They were then divided into two
groups. One group (n=25) received gonadorelin (100 µg) 24 h after the PG
treatment, while the other group (n=35) served as controls without any further
treatment. No short cycles were observed in the control group, whereas 33% of
the cows in the treatment group exhibited premature luteal regression. PG
treatment on day 8 had no effect on the intensity of the oestrous signs. In contrast,
GnRH treatment 24 h after PG treatment weakened the oestrous signs
significantly. Thus, GnRH administration 24 h after PG treatment given 8 days
after oestrus can cause short oestrous cycles in some cows.
The fourth study explores the mechanisms behind the observed short oestrous
cycles. The aim was to confirm that the luteolysis seen during short oestrous
cycles is caused by a premature release of prostaglandin F2α (PGF2α). Further, the
aim was to study the PGF2α release pattern more closely to determine whether it
resembles the spontaneous release occurring during normal CL regression or
whether PGF2α is continuously secreted after the induced ovulations leading to
short oestrous cycles. Twenty-four heifers were allotted to four equal groups.
After oestrus synchronisation, premature luteolysis was induced with PG on day 6
or day 7 after ovulation. Gonadorelin (100 µg) was given to treatment groups to
induce premature ovulation 24 h later. Seven of twelve treated heifers showed a
short oestrous cycle of 8 to 12 days duration, while all others had an oestrous
cycle of normal length. Significant elevations in 15-ketodihydro-PGF2α (a
metabolite of PGF2α) concentrations with recurrent high peaks coincided with a
decrease in progesterone concentration and were detected in all heifers that
7
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showed a short oestrous cycle, but not in any heifers with normal oestrous cycles.
Premature release of PGF2α, which closely resembles release during spontaneous
luteolysis, caused luteal regression in these short cycles.
In conclusion, GnRH treatments given during prooestrus, clearly before the
physiological release of LH, can shorten luteal function and, thus, reduce fertility.
This disturbance can be caused at least when the GnRH treatment has been given
in combination with PG treatment. A premature release of PGF2α causes luteal
regression in these short cycles.
8
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ABBREVIATIONS
AI artificial insemination
ARG arginine
Ay Ayrshire
CL corpus luteum, corpora lutea
E-17β oestradiol-17β
ELISA enzyme-linked immunosorbent assay
FSH follicle stimulating hormone
GLY glycine
GnRH native gonadotropin-releasing hormone and its agonistic analogues
hCG human chorionic gonadotropin
HFr Holstein-Friesian
HIS histidine
i.m. intramuscular
LEU leucine
LH luteinising hormone
P4 progesterone
PG prostaglandin F2α and its agonistic analogues
PGF2α prostaglandin F2α
PRO proline
PYROGLU pyroglutamic acid
RIA radioimmunoassay
SD standard deviation
SEM standard error of mean
SER serine
TRP tryptophan
TYR tyrosine
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INTRODUCTION
Gonadotropin-releasing hormone or its agonists (GnRH) have been used to treat
reproductive disorders in cattle in Finland since the early 1980s. According to
generally accepted principles in veterinary medicine in Finland, all medical
treatments should be based on clinical examination of the animal and diagnosis of
the disorder. Hence, routine hormonal therapies in reproductive management, e.g.
oestrus synchronisation programs, are not used as a rule. In general, cattle are
treated with GnRH for the following four reasons: (1) close to the time of
artificial insemination (AI) in order to enhance pregnancy rates especially in
suspected cases of ovulation failures, (2) treatment of cystic ovarian disease, (3)
treatment of prolonged puerperal anoestrus, (4) to some extent as a post-
insemination treatment to enhance embryo survival in repeat breeder cows.
Finnish statistics on herd health control (H. Rautala, personal communication)
indicate that approximately 2% of cows are treated annually with luteotropic
injections at the time of AI, mainly with GnRH. This corresponds to 6000 to 7000
treatments. The rate of treatment has decreased during the last ten years from
about 3.5% to the above-mentioned 2%. The rate of treatment of cystic ovarian
disease was 2.3% in year 2001, corresponding to about 8000 treatments.
However, it is impossible to determine, how many of these were done with
GnRH, human chorionic gonadotropin (hCG) or progesterone-releasing devices.
In tie-stall conditions, especially during the long wintertime in Finland and in
other northern countries, silent oestrus is one of the most important causes of
subfertility. Often the only sign of oestrus is a slight vaginal mucous discharge for
1 to 4 days. Hence, it may be very difficult to decide when to call the AI
technician to inseminate the cow. Because of this, GnRH treatment is often
employed to induce ovulation close enough to insemination in hopes of enhancing
the pregnancy rate. Under these circumstances, GnRH treatment may be given
even as long as one or two days before, or even after the physiological luteinising
hormone (LH) surge. It has been suspected that incorrectly timed GnRH
injections may reduce fertility.
The original idea of the present dissertation was to find and characterise possible
negative effects of incorrectly timed GnRH treatments on reproductive functions.
To test the hypothesis of negative effects, two models were established. In the
first model, GnRH treatment was given 24 to 72 h after administration of
prostaglandin F2α or its agonists (PG), in other words approximately 0 to 2 days
before the expected physiological LH surge. In the second model, GnRH
11
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treatment was administered 0 to 48 h after ovulation. Ovulation, subsequent
follicular growth, luteal function and cycle lengths etc. were investigated in order
to detect changes in reproductive functions. In the subsequent experiments, the
changes in reproductive functions caused by incorrectly timed GnRH treatments
were studied more closely.
12
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REVIEW OF LITERATURE
1. Normal oestrous cycle of cattle
The cow is polyoestrous, i.e. oestrous cycles continue throughout the year, unless
the cow becomes pregnant. The length of the normal oestrous cycle is 21±3 days
in cows and 20±3 days in heifers. The oestrous cycle is commonly divided into
four periods: prooestrus, oestrus, metoestrus and dioestrus. Sometimes it is also
divided into two periods based on ovarian findings: the follicular phase,
comprising prooestrus, oestrus and the beginning of metoestrus, and the luteal
phase comprising the rest of the oestrous cycle. For many breeds of cows the
duration of oestrus is on average 15 hours, although there is good evidence for
modern Holstein that it is much less. The normal variation is, however, wide, viz.
2 to 30 hours. The lengths of the other periods are more difficult to define. LH
surge takes place during the first 6 to 12 hours of oestrus, initiating the processes
leading to ovulation, which normally occurs during the first hours of the
metoestrus, about 24 to 30 hours after the onset of oestrus. Corpus luteum (CL)
begins to develop from the cells originating from the walls of the ovulated
follicle, and after a couple of days it starts gradually produce more and more
progesterone (P4). At the end of dioestrus, the endometrium begins to secrete
prostaglandin F2α (PGF2α), which causes CL regression, luteolysis. During
prooestrus, the maturing dominant follicle produces gradually increasing
oestradiol-17β, which causes, with simultaneous absence of P4, behavioural and
other signs of oestrus. Follicular growth during the oestrous cycle is recurrent, i.e.
it occurs as so-called follicular waves. During a normal cycle, two or three
(sometimes four) waves can be detected. Thus, smaller and larger, growing and
regressing, follicles can be seen practically at any time during the cycle. The main
endocrinological events during an oestrous cycle are illustrated in Figure 1. To
achieve optimal pregnancy rates, AI should occur 6 to 24 hours before ovulation
(Trimberger, 1948).
2. Gonadotropin-releasing hormone
Isolation and chemical characterisation of gonadotropin-releasing hormone in
1971 by Schally and Guillemin, who were awarded the Nobel Prize for these
accomplishments, was probably one of the most significant occurrences in the
research into the neuroendocrine control of reproduction. After this, the
translation from basic discovery to clinical usefulness with various indications
was swift in human medicine (Conn and Crowley, 1991).
13
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Figure 1. Schematic presentation of main endocrinological events during an oestrous cycle of cattle. 
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Basic research and clinical applications of gonadotropin-releasing hormone in
veterinary medicine developed soon thereafter. Synthesis of a decapeptide having
gonadotropin-releasing hormone activity (Geiger et al., 1971) made the hormone
readily available for research on its use in animal reproduction. Since the release
of pituitary gonadotropins after administration of GnRH was reported in cattle
(Kaltenbach et al., 1974; Kinder et al., 1975), studies have been undertaken to
evaluate its effect on ovarian function and on the oestrous cycle, e.g. on the
luteinisation of ovarian cysts (Bierschwal et al., 1975; Cantley et al., 1975;
Bentele and Humke, 1976; Christl, 1976; Garverick et al., 1976; Saalfeld and
Hollmann, 1976; Seguin et al., 1976), on stimulation of follicular development
(Mellin et al., 1975; Shareha et al., 1976), and on treatment of delayed ovulation
(Bentele and Humke, 1976). The finding that ovulation could be induced by
GnRH (Baker et al., 1973; Seeger and Humke, 1975) in a way similar to hCG
(Puschel, 1974) suggested the feasibility of studying its effects on the fertility of
artificially inseminated cows, since one of the major factors determining the
success of artificial breeding is the proper timing of insemination in relation to
ovulation.
GnRH is a straight-chain decapeptide (Figure 2) synthesised in cell bodies of
neurosecretory neurons located in the mediobasal hypothalamus and transported
by their axons to circumscribed areas of the median eminence. Here they are
released into the capillary plexus of the portal vascular system and transported to
the anterior pituitary gland (Beattie, 1982; Thatcher et al., 1993). GnRH has been
found in the central nervous system of all species of vertebrates examined. Both
the natural and synthetic decapeptides release LH and follicle stimulating
hormone (FSH) and induce ovulation in all mammalian species so far examined.
Passive immunization of a variety of mammalian species with an antiserum to
GnRH reduces blood levels of both FSH and LH and blocks ovulation.
Collectively, these observations indicate that the decapeptide represents the
moiety responsible for the release of LH and FSH (Beattie, 1982). Plasma half-
life of GnRH is short, two to four minutes (Bennett and McMartin, 1978;
Handelsman and Swerdloff, 1986).
GnRH is a pyroglutamic acid peptide. The amino-terminal tripeptide and
tetrapeptide fragments of GnRH do not stimulate gonadotropin release. The
carboxy-terminal octapeptide and nonapeptide also have negligible gonadotropin-
releasing activity. Individual amino acid substitutions drastically alter the
gonadotropin-releasing activity of the native molecule. In general, the amino
acids in positions 1 and 2 and from positions 4 to 10 appear to be involved only in
the binding of GnRH to its target-tissue receptors and in exerting conformational
effects. However, histidine-2 and tryptophan-3 exert an important functional
15
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effect, since substitution of these L-amino acids with other D-amino acids
produces analogues of GnRH with a significant loss in gonadotropin-releasing
activity and even potent antagonistic properties. Deletion of positions 2 and 3 also
leads to dramatic losses in gonadotropin-releasing activity (Beattie, 1982).
Alterations in the chemical structure of the native GnRH molecule have led to the
synthesis of potent GnRH agonists. Substitutions usually involve replacement of
the glycine molecules at positions 6 and 10 with a D-amino acid at position 6 and/
or an N-ethylamide group at position 10 (Thatcher et al., 1993). The design of
GnRH agonists has been directed toward stabilisation of the molecule against
enzymatic attack, increasing binding to plasma proteins and membranes, and
increasing the affinity of the agonist for the GnRH receptor (Conn and Crowley,
1991). At least the following GnRH analogues and GnRH agonists are or have
been available commercially: gonadorelin (native-like GnRH; gonadorelin
diacetate tetrahydrate or gonadorelin hydrochloride), buserelin (D-serine at
Figure 2. Chemical structure (amino acid sequence) of gonadotropin-releasing hormone (adapted
from Beattie, 1982). 
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position 6 and ethylamide at position 10), fertirelin acetate (ethylamide at
position 10) and deslorelin (D-tryptophane at position 6 and ethylamide at
position 10). In Finland, two preparations are available at the moment: Fertagyl
(gonadorelin 0.1 mg/ml; Intervet International B.V., The Netherlands) and
Receptal (buserelin 4 µg/ml; Intervet International B.V., The Netherlands).
Owing to alterations in chemical structure, marked differences exist between the
various GnRH analogues in their relative potencies to release LH and FSH in
cattle (Nawito et al., 1977; Chenault et al., 1990). For example, fertirelin acetate
was approximately four to ten times more potent than gonadorelin as measured by
LH and FSH release during the luteal phase of the bovine oestrous cycle;
buserelin was 50 times more potent than gonadorelin (Chenault et al., 1990).
Based upon a carryover effect of a moderate dose followed by a low dose of these
products, the pituitary’s gonadotropes apparently become refractory to GnRH for
up to 48 h after injection of doses greater than or equal to 50 µg fertirelin acetate,
500 µg gonadorelin and 10 µg buserelin. A single intramuscular (i.m.) injection of
native GnRH and GnRH agonists gives a predictable release of both LH and FSH
into the peripheral circulation over a 3 h period (Thatcher et al., 1993).
3. Applications of GnRH for reproductive management
Control of ovarian function and reproductive efficiency in cattle with GnRH has
been studied intensively (review by Thatcher et al., 1993). The main clinical
applications of GnRH treatments are as follows: treatment at the time of AI in
normal and repeat breeder cows to improve fertility, treatment of cystic ovarian
disease, treatment of anoestrus, oestrus synchronisation programmes, post-
insemination treatments to improve fertility, postpartum reproductive
management to improve fertility later at the breeding period and treatment of
embryo transfer recipients to enhance embryo survival. In the present review, only
the treatments during oestrus, at the time of AI, are discussed in detail.
17
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4. GnRH treatments during perioestrus and at the time of AI to improve
fertility
4.1. The effect of GnRH treatments on pregnancy rate
A considerable number of studies have examined whether GnRH treatments given
at the time of AI are able to improve pregnancy rates in cattle. Approximately 49
experiments from 36 published research articles that reported clinical trials in
which GnRH was used to treat dairy cattle (one trial with beef cattle) at the time
of AI are summarised in Tables 1 and 2. The studies were collected from scientific
journals published from 1974 on, thus covering practically the entire history of
the use of GnRH in veterinary clinical trials. Probably the majority of the studies
dealing with this topic are reviewed here, with exception of perhaps some in
national journals and papers published in languages other than English. Because it
is obvious that the serial number of AI modifies the effect of the treatment (Mee
et al., 1990; Stevenson et al., 1990), the studies have been divided into those
where the treatment was given at the first or second AI postpartum (Table 1) and
in repeat breeders (cows not conceiving after at least two previous inseminations;
Table 2).
In 19 of 31 experiments where GnRH treatment was given at the time of first or
second AI, native GnRH (or gonadorelin) was used, while the remaining 12
experiments utilised agonistic analogues, buserelin, fertirelin acetate and
sulfagon. The doses generally varied around 100 µg of native GnRH or
corresponding agonistic analogues. Only in a few experiments were remarkably
larger doses used. Generally, the experimental animals were parous cows; only in
five trials were some, or all, animals heifers. The treatment was usually given at
the time of AI; in five experiments, the treatment was given before AI, but never
more than 15 hours before. In most experiments, a numerically increased
pregnancy rate after GnRH treatment was detected, but the difference was
statistically significant only in six trials (Table 1). Each of these six trials
involved more than 200 animals. In one trial, a negative effect of GnRH on
pregnancy rate was found when the statistical significance was calculated
separately between each treatment and the control group (Chenault, 1990; Table
1).
Mee et al. (1990) reviewed 16 studies (17 experiments; all of these included in
Table 1) reporting the administration of various doses of GnRH to dairy cattle at
the time of AI or 0 up to 6 hours preceding AI. A significant (6 trials) or
nonsignificant (5 trials) advantage in pregnancy rate was reported, whereas others
(6 trials) reported no benefit of GnRH administration on pregnancy rates at first
18
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service. Overall, the studies demonstrated an advantage in pregnancy rate of 6
percentage points (53 vs. 59%) or an 11% improvement for cows treated with
GnRH at the time of first AI compared with untreated controls. Based on these
studies and their own data, Mee et al. (1990) concluded that GnRH administration
to dairy cattle at first services postpartum fails to improve pregnancy rates and
that it is inadvisable to recommend the use of GnRH at first services. Based on
the review by Mee et al. (1990), Thatcher et al. (1993) came to the conclusion in
their review article that, as changes in pregnancy rates varied among studies in
first service dairy cows from -7 to +17%, it is difficult to accept that GnRH is
eliciting a predictable increase in fertility that can be reliably applied from herd to
herd.
Repeat breeding has considerable impact on the economy of dairy farmers
(Bartlett et al., 1986; Lafi and Kaneene, 1992; Lafi et al., 1992) and has been the
subject of a number of reviews (Casida, 1961; Ayalon, 1978; Hawk, 1979;
Ayalon, 1984; Levine, 1999) presenting diverse explanations for the syndrome. In
a review by Ayalon (1984), incidence of repeat breeding problems in various
countries ranged from 10 to 18%. In Finland, however, according to the strict
definition that follows, the incidence was only 1.0%, but when the criterion was
only more than three AIs, the incidence was 7.5% (Rautala, 1991). The current
definition of repeat breeding includes pregnancy failures occurring after three or
more AIs performed at oestrus with normal inter-oestrus intervals in the absence
of detectable abnormalities (Zemjanis, 1980). However, in most studies dealing
with the effect of GnRH given at the time of AI in repeat breeders, they were
classified as cows that return to oestrus for a third or further service, and without
any other definitions.
Altogether the results of 18 experiments that studied the effect of GnRH given at
the time of AI in repeat breeders are shown in Table 2. In all of these, with two
exceptions, native GnRH (or gonadorelin) was used. The dosages used were also
consistent, viz. 100 µg of native GnRH or agonistic analogue corresponding to
this, again with only two exceptions. The treatment was usually given at the time
of AI, in three experiments 0 up to 15 hours before AI. In 14 experiments, a
numerically increased pregnancy rate after GnRH treatment was detected; in five
of these the increase was significant. All five of these were among those eight
trials using more than 300 AIs. In three experiments, a numerical, but not
significant, decrease in pregnancy rate, 9 to 15 percentage points, was detected.
Stevenson et al. (1990) reviewed eight studies (nine experiments) where GnRH
was used as a treatment for repeat breeding at the time of, or 0 to 12 hours
preceding, AI (all of these are included in Table 2). Collectively, these studies
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Table 1. Summary of studies where GnRH treatment was given at first or second AI. If a study included several treatment groups (e.g. several 
doses), the results for the groups are expressed in separate rows but the result for a control group is expressed only in the first row. 
 
Treatment Pregnancy rate 
Controls Treated 
Study Order 
of AI GnRH Dose, 
µg 
No. 
herds 
No. AI 
 %  % 
P value 
Günzler et al. (1974) I native 1000 Many 200 55/100 55.0 56/100 56.0 n.s. 
Goldbeck (1976) I native 1000 Many 214 73/107 68.2 87/107 81.3 <0.0514 
Günzler et al. (1976) I native 400 Many 200 59/100 59.0 70/100 70.0 n.s. 
Günzler et al. (1976) II native 400 Many 200 60/100 60.0 71/100 71.0 n.s. 
Grünert et al. (1978) I 13 native 1000 ? 278 95/140 67.9 112/138 81.2 <0.01/<0.0515 
Mori and Takahashi (1978) I ? fertirelin  100 1 59 19/31 61.3 21/28 75.0 n.s. 
Schels and Mostafawi (1978) I gonadorelin 125 1 218 54/109 49.5 64/109 58.7 n.s. 
Leidl et al. (1979) I buserelin 10 Many 397 124/220 56.4 118/177 66.7 <0.05 
Leidl et al. (1979) II buserelin 10 Many 180 50/85 58.8 56/95 58.9 n.s. 
Vahdat and Whitmore (1980) 1 I native 100 ? 96 27/48 56.3 26/48 54.2 n.s. 
Westhuysen (1980) 2 I buserelin 20 ? 76 17/32 53.1 29/44 65.9 <0.05/n.s.15 
Holtemöller (1981) I buserelin 10 4 119 23/54 42.6 34/65 52.3 n.s.13 
Moller and Fielden (1981) 3 I buserelin 10 3 576 139/284 48.9 170/292 58.2 <0.05 
Nakao et al. (1983) I fertirelin 100 Many 1194 293/589 49.7 346/605 57.2 <0.05/<0.0115 
Lee et al. (1983) I native 100 3 300 58/146 39.7 76/154 49.4 n.s.14 
Lee et al. (1983) 2 I native 100 3 185 64/93 68.8 59/92 64.1 n.s. 
Fielden and Moller (1983) 3,4 I buserelin 10 7 1302 371/647 57.3 414/655 63.2 <0.05 
Stevenson et al. (1984) I native 100 1 328 83/182 45.6 69/146 47.3 n.s. 
Stevenson et al. (1984) II native 100 1 204 48/104 46.2 55/100 55.0 n.s. 
Lee et al. (1985) I native 100 1 24 6/12 50.0 6/12 50.0 n.s. 
Anderson and Malmo (1985) 3 I gonadorelin 250 25 3502 1529/2828 54.1 396/674 58.8 n.s.16 
Anderson and Malmo (1985) 3 II gonadorelin 250 25 1242 654/1156 56.6 50/86 58.1 n.s. 
Pennington et al. (1985) 5 I native 100 2 313 79/152 52.0 82/161 50.9 n.s. 
Pennington et al. (1985) 5 II native 100 2 141 37/69 53.6 37/72 51.4 n.s. 
Lucy and Stevenson (1986) 6 I native 100 1 109 14/55 25.5 23/54 42.6 n.s. 
Alacam et al. (1986) I ? analogue 25 ? 69 23/36 63.9 27/33 81.8 <0.01/n.s.15 
Dmitriev et al. (1986) I ? sulfagon 10 ? 100 26/54 48.1 26/46 56.5 n.s.14 
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Coleman et al. (1988) 7 I fertirelin 50 ? 86 20/28 71.4 23/30 76.7 n.s. 
  fertirelin 100     23/28 82.1 n.s. 
Lewis et al. (1990) 8 I native 100 2 258 60/127 47.2 58/131 44.3 n.s. 
Lewis et al. (1990) 8 II native 100 2 126 27/66 40.9 27/60 45.0 n.s. 
Mee et al. (1990) I native 100 1 300 44/117 37.6 34/105 32.4 n.s.14 
Mee et al. (1990) 9 I native 100 1 169 29/67 43.3 23/50 46.0 n.s. 
Chenault (1990) 10 I + II fertirelin 25 10 1447 117/243 48.1 105/240 43.8 n.s. 
  fertirelin 50     100/242 41.3 n.s. 
  fertirelin 75     100/240 41.7 n.s. 
  fertirelin 100     95/242 39.3 n.s./<0.0515 
  buserelin 10     95/240 39.6 n.s. 
Valks (1996) 11 I gonadorelin 250 292 2704 922/1355 68.0  71.0 n.s. 
Valks (1996) 11 II gonadorelin 250 292 989 310/480 64.6 343/509 67.4 n.s. 
Ullah et al. (1996) 12 I native 100 3 94 8/45 17.8 14/49 28.6 n.s. 
Vamerzani et al. (1999) 1 I+II buserelin
 
10 ? 35 9/20 45.0 12/15 80.0 n.s. 
 
? Information not available in the reference. 
1 Cows and heifers. 
2 Heifers. 
3 Treatment given 0-6 h before AI. 
4 Includes the material of Moller and Fielden (1981). 
5 In the groups, 23% and 25% were heifers, respectively. Treatment was given on average 6-7 h before AI. 
6 Treatment given 8 h before AI. 
7 Beef cattle. 
8 Approx. 1/3 were heifers. 
9 Treatment given 11-15 h before AI. 
10 First and second inseminations. 
11 Instead of pregnancy rate, non-return rate 56 days was calculated. 
12 Treatment given 10-12 h before AI. 
13 First AI 80%. 
14 Information not available. Calculated here with Chi-square test. 
15 Information in the reference / Calculated here with Chi-square test. 
16 After adjusting for potential confounding variables; uncorrected P<0.05. 
958/1349
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demonstrated an overall advantage in pregnancy rate of seven percentage points,
corresponding to an 18% increase, for repeat breeders treated with GnRH
compared with untreated repeat breeders. According to their own findings, they
consistently observed an increase in pregnancy rates after GnRH treatment of
repeat breeders in three experiments involving cows with either normal or
abnormal periparturient conditions in seven different herds (Stevenson et al.,
1984; Phatak et al., 1986; Stevenson et al., 1988). They concluded that the
decision to utilise GnRH for repeat breeders in any herd should be weighed
against the possibility that its efficacy has not been validated consistently in all
herds. However, the preponderance of studies with repeat observations in many
locations verifies the benefit of GnRH as an effective treatment for repeat
breeders.
Tables 1 and 2 show that the results of the studies of the effect of GnRH given at
AI on pregnancy rates are inconsistent. This has led to many trials being
performed to clarify responses. While most experiments demonstrated an
increased pregnancy rate, few trials reached statistical significance. For many
trials, lack of significance can be attributed to insufficient sample size (Morgan
and Lean, 1993). Meta-analytical techniques have been used to combine data
from many studies into a single analysis (L’Abbe et al., 1987). This is a
potentially powerful technique for evaluating conflicting clinical trial results and
is well suited to resolving concerns about the efficacy of treating cows with
GnRH at insemination to improve fertility (Morgan and Lean, 1993). In the study
by Morgan and Lean (1993), data from 40 trials described in 27 published papers
were subjected to meta-analysis to evaluate the effects of such treatments on a
total of 19,019 cows involved in these studies. Morgan and Lean stratified these
data by trial and by the effects of dose of GnRH, type of GnRH and number of
times inseminated (first, second, or third and greater that were classified as repeat
breeders) into five groups as follows: eight trials used GnRH agonistic analogues
(buserelin, fertirelin acetate, sulfagon) at first AI, 10 trials used doses of native
GnRH of less than 125 µg at first AI, 3 trials used doses of native GnRH greater
than, or equal to, 250 µg at first AI, 8 trials investigated the effect of native GnRH
or its agonistic analogues at second AI, and 11 trials evaluated the effect of native
GnRH or its agonistic analogue on repeat breeders. The collected information was
used to calculate relative risk and 95% confidence intervals for relative risk of
pregnancy in treated cows using Mantel-Haenszel test. Mantel-Haenszel relative
risk estimation is a means of evaluating pooled data that allows one to control for
the effect of stratification and is an appropriate method for meta-analysis (L’Abbe
et al., 1987).
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Table 2. Summary of studies where GnRH treatment was given at the time of the third or subsequent insemination. 
 
Treatment Pregnancy rate 
Controls Treated 
Study 
GnRH Dose, 
µg 
No. 
herds 
No. AI 
 %  % 
P 
value 
Leidl et al. (1979) buserelin 10 Many 119 24/49 49.0 38/70 54.3 n.s.8 
Lee et al. (1983) native 100 26 346 77/161 47.8 135/185 73.0 <0.001 
Stevenson et al. (1984) native 100 1 97 27/53 50.9 29/44 65.9 n.s. 
Anderson and Malmo (1985) 1 gonadorelin 250 25 361 160/302 53.0 26/59 44.1 n.s. 
Pennington et al. (1985) 2 native 100 2 92 20/43 46.5 27/49 55.1 n.s. 
Phatak et al. (1986) native 100 5 961 177/469 37.7 231/492 47.0 <0.01 
Roussel et al. (1988) native 100 9 379 38/96 39.6 158/283 55.8 <0.01 
Stevenson et al. (1988)  native 100 1 140 40/103 38.8 20/37 54.1 n.s. 
Stevenson et al. (1988)  native 100 1 513 108/344 31.4 74/169 43.8 <0.05 
Lewis et al. (1990) 3 native 100 2 61 13/29 44.8 11/32 34.4 n.s. 
Swanson and Young (1990) native 100 3 127 36/65 55.4 25/62 40.3 n.s. 
Stevenson et al. (1990) native 100 6 759 112/353 32.1 165/406 41.6 <0.058 
BonDurant et al. (1991) native 100 14 963 184/468 39.3 214/495 43.2 n.s. 
Mee et al. (1993) native 7 1 44 2/14 14.3 13/30 30.2 n.s. 
Archbald et al. (1993) native 100 1 281 45/139 32.4 47/142 33.1 n.s. 
Archbald et al. (1993) 4 native 100 1 236 40/129 31.0 43/107 40.2 n.s. 
Valks (1996) 5 gonadorelin 250 292 411 132/204 64.7 139/207 67.1 n.s. 
Vamerzani et al. (1999) 6 buserelin 10 ? 35 8/20 40.0 10/15 66.7 n.s. 
 
1 Treatment given 0-6 h before AI. 
2 In the groups, 23% and 25% were heifers, respectively. Treatment was given on average 6-7 h before AI. 
3 Approximately 1/3 were heifers. 
4 Treatment given about 9 h before AI. 
5 Instead of pregnancy rate, non-return rate 56 days was calculated. 
6 Cows and heifers. 
7 50 µg, n=8; 100 µg, n=14; 250 µg, n=8 
8 Information not available. Calculated here with Chi-square test. 
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Although Morgan and Lean (1993) used strictly defined criteria in making their
meta-analysis, they made numerous errors in selecting the trials and in reporting
the number of cases in each of the five groups. The experimental design used in
one of the papers included in the group dealing with GnRH agonistic analogues at
first AI does not match the topic of the meta-analysis. In addition, data presented
in a study was reported again, along with additional data, in a later study;
however Morgan and Lean (1993) treated these two data sets as entirely separate.
In their study of low dose of GnRH at first AI, Morgan and Lean (1993) reported
only some of the data of two trials, and another paper is so unclear that it may
have been impossible for them to refer to it accurately. In their study of native
GnRH or its agonistic analogue on repeat breeders, Morgan and Lean (1993)
included only some of the data from one paper, and in one instance they included
data from a second insemination by referring to the wrong table. The worst
situation is in that portion of the meta-analysis which deals with the use of native
GnRH or its agonistic analogues at second AI. Four of the eight trials reported
here do not study the effect of GnRH given at second AI, but actually the carry-
over effects of GnRH treatments given at first AI.
Despite these many errors, it is obvious that they do not bias the results because
the number of studies and animals referred is so large and the errors seem to be
distributed quite evenly. However, the results of the meta-analysis involving
native GnRH or its agonistic analogues at the second AI should be interpreted
with caution. The analysis of pooled data of all studies revealed that the use of
GnRH at insemination significantly (P<0.05) increased the overall risk of
pregnancy by 12.5% in treated cows when compared to the controls. There was a
significant (P<0.05) increase in risk of pregnancy in cows treated with GnRH
agonistic analogues at the first AI (increase in risk of 8.0%) or high doses (  250
µg) of native GnRH at first AI (11.0%), at second AI (9.9%) and in repeat breeder
cows (22.5%). Risk of pregnancy from treatment with low doses (<125 µg) of
native GnRH at the first AI (5.2%) was not significantly different from that of the
control group. However, the relative risk of pregnancy after low doses was similar
to that of GnRH agonistic analogues, second AI and high doses of native GnRH
categories. The relative risks with 95% confidence intervals for pregnancy after
GnRH treatments at AI for these five studies and for overall combined studies are
presented in Figure 3. The authors concluded that GnRH treatment at
insemination does increase the risk of pregnancy. Results obtained from this
analysis were relatively homogenous, except that repeat breeder cows responded
better to treatment than the other groups (Figure 3). Individual trials that had
extreme results tended to be small and therefore had wide confidence intervals.
>_
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Repeat breeding may be viewed as an effect modifier for the relationship between
GnRH treatment and fertility. This observation supports the conclusion that some
cattle populations benefit more from treatment than others.
According to Thatcher et al. (1993) the concept of treating repeat breeder cows
with GnRH has become clouded because of difficulties in defining a true class of
infertile cows and uncertainty as to whether they respond specifically to GnRH. A
component of the traditional definition of a repeat breeder, as defined by Casida
(1961), is that semen quality and insemination circumstances should be optimal in
identifying this class of cows, which have greater rates of defective ova, ova loss,
fertilization failure and embryonic loss. If cows with at least three AIs are defined
as repeat breeders, it is critical that such management factors as accurate oestrous
detection, timing of insemination, handling of semen and inseminator skills are
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Figure 3. Mantel-Haenszel relative risk and 95% confidence interval for pregnancy after GnRH
treatment at AI for five studies (A to E) and for overall combined studies (F). Study A: GnRH 
agonistic analogues given at first AI, B: low doses (<125 µg) of native GnRH given at first AI, C: 
high doses ( g) of native GnRH given at first AI, D: native GnRH or its agonistic analogues
given at second AI, E: native GnRH or its agonistic analogues given to repeat breeders at AI, F: all 
studies combined. A relative risk of >1.0 indicates that pregnancy rates were higher for GnRH-
treated cows (redrawn from Morgan and Lean, 1993).  
>250 µ
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optimal, and that cows with palpable abnormalities of the reproductive tract are
excluded. This array of management factors undoubtedly contributes to the herd-
to-herd variability in the success of GnRH treatments.
In an economic assessment under American conditions, Weaver et al. (1988)
concluded that herds with conception rates of 45% or less benefited from GnRH
treatment at first or second AIs; herds with conception rates of 60% or over
benefited from GnRH treatment only at second or later AIs. According to Morgan
and Lean (1993), GnRH treatments at the time of AI reduced the number of days
open in the following way: GnRH agonistic analogues used at the time of first AI,
1.7 days; low doses (<125 µg) of native GnRH given at first AI, 1.1 days; high
doses (  250 µg) of native GnRH given at first AI, 2.3 days; and native GnRH or
its agonistic analogues given to repeat breeders at AI, 4.7 days. It has been
estimated that in Finnish conditions the lengthening of one day in calving interval
from 11 months causes an economic loss of about 1.0 to 1.3 • (J. Taponen,
unpublished). Because of veterinary and drug expenses, it is questionable whether
this treatment is cost-effective in Finland, even in repeat breeders.
In conclusion, it seems obvious that administration of GnRH and its agonistic
analogues at the time of AI does increase pregnancy rates. The magnitude of the
increase is a function of the serial number of AI, being greatest in repeat breeder
cows. However, it is important to understand the differences among locations,
herds, management and physiological states that contribute to the differential
fertility responses to GnRH treatments (Thatcher et al., 1993).
4.2. Mechanisms and factors through which GnRH may modify fertility
GnRH treatment at the time of AI may enhance fertility in a number of ways.
However, the mechanisms through which GnRH may modify fertility have not
been elucidated (Morgan and Lean, 1993). Treatment with GnRH during oestrus
may influence time of ovulation, fertilisation rates, CL development, P4 secretion,
and embryonic survival (Stevenson et al., 1984). GnRH likely acts by effecting
the release of FSH and LH, but its direct effect on the reproductive tract cannot be
ignored, in view of the fact that GnRH-like molecules have been isolated from
ovarian follicles (Ying et al., 1981). Furthermore, ovulation can be induced in
hypophysectomised rats following GnRH administration (Corbin and Bex, 1981).
The finding that ovulation can be induced by GnRH (Baker et al., 1973; Seeger
and Humke, 1975) led to numerous studies of its effects on the fertility of
artificially inseminated cows, since one of the major factors determining the
>_
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success of artificial breeding is the proper timing of insemination in relation to
the rupture of the ovulatory follicle (Schels and Mostafawi, 1978). To achieve
satisfactory pregnancy rates, optimal timing of the deposition of semen and
occurrence of ovulation is of utmost importance because of the relatively brief
fertile life of both sperm and ovum. Moreover, timing of insemination is under the
direct control of man and does not depend on the sexual receptivity of the animal.
Therefore the possibility of delays in fertilisation is increased. High conception
rates can be expected only if insemination takes place 7 to 18 hours before
ovulation (Trimberger and Davis, 1943). This may be impeded if oestrus onset is
not observed or if there are physiological or pathological variations of follicle
rupture and ovum release (Schels and Mostafawi, 1978). It has been suggested
that GnRH-induced ovulation may provide greater synchrony between the time of
insemination and the time of ovulation (Moller and Fielden, 1981; Stevenson et
al., 1988).
Since the GnRH peak normally occurs near the onset of oestrus (Mori et al.,
1974), an injection of GnRH before AI would be more likely to correct an
asynchrony of breeding and ovulation than an injection of GnRH at AI (Pennigton
et al., 1985). Stevenson et al. (1984) suggested that conception rates increased
when cows were treated in the first 5 to 8 hours of oestrus. Therefore, accuracy of
heat detection and management could influence the magnitude of response to
GnRH treatment. The findings of Rosenberg et al. (1991) and Mee et al. (1990)
indicated that timing GnRH injections close to detection of oestrus contributes to
the success of GnRH treatment at first postpartum inseminations in cows with
low conception rates. In cows inseminated two to four times, GnRH injections
close to detection of oestrus needed to be coupled with inseminations 4 to 30
hours after detection of oestrus to obtain an increase in fertility as opposed to
early inseminations, less than 3 hours from the detection of oestrus (Rosenberg et
al., 1991). GnRH administration early in oestrus and AI 12 to 15 hours later gave
better results than the treatment at the time of AI, although not better than in
control (Mee et al., 1990). The role of GnRH in indirectly altering the rate or
efficiency of oocyte maturation in low fertility cows warrants study (Thatcher et
al., 1993).
The effect of GnRH given at oestrus on the subsequent P4 concentration and its
possible influence on fertility through this mechanism has been studied and
discussed widely. BonDurant et al. (1991) proposed that GnRH may reduce early
embryonic mortality by enhancing the luteinisation of thecal and granulosa cells
through the increased LH surge. The subsequent increase in P4 secretions may
improve maternal recognition of the conceptus. Maurer and Echternkamp (1982)
found that cows with higher preovulatory LH surges and more rapid rise of P4
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after ovulation showed higher embryonic survival. Also Lee et al. (1985) and
Ullah et al. (1996) proposed that higher pregnancy rates in cows injected with
GnRH are probably the result of detected increased P4 production and enhanced
embryo survival. In addition, Mee et al. (1993) found that higher P4 levels were
due to an increased proportion of large luteal cells in the CL and possibly due to
increased concentration and pulse frequency of FSH secretion. However, Lewis et
al. (1990) did not detect any significant increase in P4 concentrations after GnRH
treatment, and Lucy and Stevenson (1986) found that injection of GnRH during
perioestrus, either shortly before or concurrent with the preovulatory surge of LH,
attenuated subsequent progesterone concentrations in serum during the first 7
days of the oestrous cycle in repeat breeders. Based on this finding they
concluded that improved fertility detected in their study may be associated with
delayed or slowly rising P4 concentrations after ovulation. Despite the variable
nature of results, it is obvious that GnRH increases P4 production, in view of few
results to the contrary.
Based on their meta-analytical study, Morgan and Lean (1993) concluded that the
type of GnRH (native or agonistic analogue) used at the time of AI did not greatly
influence the risk of pregnancy for cows at first service. Both groups had very
similar relative risks and confidence intervals (Figure 3). GnRH dosage may
influence results slightly, as all higher dose studies showed a positive fertility
effect from GnRH treatment, but relative risk of pregnancy did not differ
markedly from that achieved with lower doses of GnRH.
There are many other sources for considerable variations in the results of
experiments studying the effect of GnRH administered at AI on pregnancy rate,
and not nearly all of them have been elucidated. Geographic location,
physiological status of cows, breed of cattle, nutrition, herd management and
overall herd fertility have also been proposed as factors contributing to the
variation of results (Morgan and Lean, 1993). BonDurant et al. (1991) ascribed
part of the positive result in their study to an improvement in management
practices at the farms involved in the experiment. The most positive responses to
treatment were recorded in cattle that had high daily milk production at the time
of AI (>25 kg, Grünert et al., 1978; >30 kg, Goldbeck, 1976), but contrary to this,
Holtemöller (1981) and Nakao et al. (1983) detected the best response in the
middle level (20 to 25 kg and 25 to 30 kg, respectively) and no response in the
highest level (>25 kg and >30 kg, respectively). Lee et al. (1983) found no effect
of milk production. In addition, the effect of the length of time from calving to
first AI has been inconsistent. The best treatment effect has been found in cattle
mated relatively early, 4 to 6 weeks, after calving (Grünert et al., 1978; Goldbeck,
1976). However, Nakao et al. (1983) observed a greater response to treatment
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when cows were mated after 101 days postpartum, and Moller and Fielden
(1981), Lee et al. (1983) and Chenault (1990) did not detect any influence. Young
cows (parity 1 to 2 or 3) seem to benefit more from the GnRH treatment than
older cows (Grünert et al., 1978; Holtemöller, 1981; Nakao et al.; 1983).
However, no effect has been detected on heifers, probably due to the fact that they
are not exposed to the type of physiological demands and changes placed on
lactating cows (Lee et al., 1983). Overall herd fertility has been proposed to have
a great impact on the effect of GnRH treatment. Coleman et al. (1988) have
summarised that treatment with GnRH at AI might be more beneficial in herds
with below-average conception rates or in identified low-fertility cows compared
with herds or cows of average or above-average fertility. The better response to
GnRH treatments seen in repeat breeder cows may be explained by this fact, since
the fertility of these cows is generally low. In the studies summarised in Table 2,
the initial pregnancy rates of the study populations, repeat breeders, were below
50% in 14 of 18 trials and even below 40% in 7 trials.
5. Possible negative effects of GnRH administered during perioestrus
Although the effect of GnRH treatment given at the time of AI on pregnancy rate
has been mainly positive at least numerically, ten of 55 trials (or subgroups of
trials) showed a lower pregnancy rate in treated animals than in control animals
(Tables 1 and 2). Although the decrease was generally small, two studies showed
a significant negative effect of GnRH on pregnancy rate (Mee et al., 1990;
Chenault, 1990). In Mee et al. (1990), where both the timing of GnRH treatment
and the timing of AI (early / late after first detected oestrus) were studied, only
treatments of GnRH early in oestrus and AI late in oestrus were found to restore
pregnancy rates to control values. In the other groups, pregnancy rates were lower
than in control group. The authors concluded that this treatment contrast
illustrates an inhibitory effect of GnRH on pregnancy rates, based on its timing
relative to the onset of oestrus or the onset of the preovulatory surge of
gonadotropins.
When GnRH treatment was used in combination with oestrus induction using PG
treatment, some evidence was detected of possible negative effects of GnRH on
subsequent luteal function or fertility. Stevens et al. (1993) administered GnRH
simultaneously with PG on day 8 or 10 of the oestrous cycle. Cows that ovulated
prematurely (day 8: 4/8, day 10: 1/8) failed to develop and maintain a fully
functional CL, and all returned to oestrus 7 to 13 days after the induced ovulation.
In addition, Schmitt et al. (1996) reported a significantly lower pregnancy rate
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after timed AI following GnRH, when GnRH was injected 24 h after PG,
compared to AI at detected oestrus after PG. No difference was found when
GnRH was given 48 h after PG.
Despite intensive research on the effects of GnRH, very few studies have been
published on GnRH treatments given during the first days after ovulation in
cattle. Macmillan et al. (1986) reported a reduction in pregnancy rate by 10.9%
units when buserelin (5 µg) was administered 1 to 3 days after insemination. Ford
and Stormshak (1978) found significantly reduced P4 concentrations when native
GnRH (100 µg) was given 55 h after detected oestrus. Later, Rodger and
Stormshak (1986) and Martin et al. (1990) studied the influence of native GnRH
(100 µg) given on day 2 post-oestrus (day of oestrus = day 0) on subsequent luteal
function. In both studies, a tendency toward reduced P4 concentrations was
detected. It has been shown that early embryonic loss is probably associated with
a complex endocrine syndrome, which could be manifested by a lower capacity to
synthesise and/or release CL-progesterone (Lamming et al., 1989). It is, however,
questionable that the reduced fertility reported by Macmillan et al. (1986) can be
explained by an impaired luteal function, because the reasons behind the decline
of P4 concentration caused by the GnRH given during metoestrus are not yet
known.
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AIMS
The overall aim of the present thesis was to find and characterise possible
negative effects of GnRH treatments given during perioestrus on reproductive
functions, with special focus on the prostaglandin-induced oestrus period, and
their effects on the ovulatory follicle, ovulation, subsequent follicular growth, and
luteal function. The specific aims of the studies were as follows:
to investigate, under controlled study conditions, the influence of
exogenous GnRH on oestradiol secretion of the ovulatory follicle, on
occurrence of ovulation, development and function of the corpus luteum
and growth of a dominant follicle after ovulation, when GnRH treatment
was given before the expected physiological LH surge;
to investigate, under controlled study conditions, the influence of
exogenous GnRH given shortly after ovulation on the development and
function of the corpus luteum and the length of the subsequent oestrous
cycle;
to confirm, under field conditions, our earlier findings that PG treatment
given 8 days after oestrus followed by administration of GnRH 24 h later
can cause remission of luteal function and, thus, short oestrous cycles;
to study the effects of PG treatment alone before mid-diestrus, and
PG+GnRH treatment on oestrous signs under farm conditions;
to confirm, under controlled study conditions, that CL regression in
normally cycling dairy heifers seen during short oestrous cycles induced
with cloprostenol and GnRH 24 h apart is caused by a premature release
of PGF2α (monitored by its main metabolite, 15-ketodihydro-PGF2α), and
further, to study the PGF2α release pattern more closely to determine
whether it resembles the spontaneous release occurring during normal
luteolysis or whether PGF2α is continuously secreted after the induced
ovulations leading to short oestrous cycles.
•
•
•
•
•
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MATERIALS AND METHODS
Two types of studies were included in the present work. Firstly, three experiments
were carried out in controlled environments at research farms at the College of
Veterinary Medicine, Department of Obstetrics and Gynaecology, Hautjärvi,
Finland (Studies I and II) and at the University of Helsinki, Viikki Research Farm
(Study IV). Secondly, in the field study, data were collected on 19 commercial
dairy herds on typical Finnish family-managed dairy farms (Study III).
1. Animals
A total of 102 animals, heifers and cows, were used in these experiments. Number
of animals in each study, breed, parity, age of the heifers at the beginning of the
experiment and interval from calving to the beginning of the experiment in the
cows are presented in Table 3. All animals had shown normal oestrous cycles and
were clinically healthy. They were stanchioned and fed grass silage, dry hay, and
corn according to Finnish standards (Studies I, II, IV). In the field study (Study
III), the housing and management practices were not strictly monitored, but were
according to Finnish standards.
2. Experimental design
The effects of GnRH - when given during prooestrus (I) or during metoestrus (II)
- on ovulation, subsequent follicular growth, luteal function and cycle length were
investigated in the two first experiments. In addition, the purpose was to
undertake a closer examination of the short oestrous cycles observed in Study I:
their appearance (III) and mechanisms behind these cycles (IV). In Studies I, III
and IV, where the effects of GnRH given during prooestrus (0 to 2 days before LH
surge) were studied, PG was administered on days 6 to 9 after ovulation in order
to induce prooestrus. In Studies I, II and IV, PG treatment was used also to induce
oestrous cycle synchronisation. In all of these PG treatments, a single i.m.
injection of 0.5 mg of cloprostenol [EstrumatR 0.25 mg/ml, Mallinckrodt
Veterinary Ltd., Harefield, Uxbridge, England (I, II, III); EstrumatR 0.25 mg/ml,
Schering-Plough A/S, Denmark (IV)] was administered.
In all studies, gonadorelin (FertagylR 0.1 mg/ml, Intervet International B. V.,
Boxmeer, Holland) was used as a GnRH treatment. The dose was 100 µg i.m. in
Studies I, III and IV, while in Study II, 250 µg i.m. was used. GnRH is used in the
text to indicate gonadorelin treatment.
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In Studies I, II and IV, transrectal ultrasonographic examinations of the ovaries
were performed once daily after PG treatment to monitor ovulation. After this,
ovarian structures were followed during the first half of the subsequent oestrous
cycle (I, IV) or throughout the subsequent oestrous cycle (II). Blood (I, II, IV) or
whole milk (III) samples were collected for hormone determinations. An overall
summary of the treatments, ultrasonographic examinations and samplings in all
studies are presented in Table 4.
2.1. GnRH during induced prooestrus (I)
The experiment included GnRH treatments at three different time points (T24,
T48, T72) and one control manipulation (C). Every animal was assigned once to
each of these four manipulations. From day 5 or 6 after ovulation, daily
transrectal ultrasound examinations were carried out to determine the day when
the dominant follicle ceased to grow. On day 8 - or if the dominant follicle had
continued to grow between days 7 and 8 - on day 9 after ovulation, PG was
administered to induce luteolysis. After this, the animals were given GnRH as
follows: treatment 1) 24 h after PG (T24; in article I called T1), 2) 48 h after PG
(T48; T2), 3) 72 h after PG (T72; T3), or 4) no gonadorelin (control manipulation,
C).
Ultrasonographic examinations were performed daily from the day of PG
treatment until ovulation and thereafter on days 1, 2, 3, 5, (6), 7, 8, and (9) (On
days 6 and 9 if necessary or possible; day 0 = day of ovulation).
Table 3. Number of animals in each study, breed, parity, age of the heifers at the beginning of the 
experiment and interval from calving to the beginning of the experiment in cows. 
 
Study Number of 
animals 
Breed Parity Age at beginning 
of experiment, 
months 
Interval from calving 
to experiment, months 
I 6 heifers 
3 cows 
Ay  
1-2 
18-21  
3-6 
II 6 heifers 
3 cows 
Ay  
1-2 
12-15  
9-13 
III 60 cows Ay (50) 
HFr (10) 
1-5, average 
2.6 
 2-15, 
average 6.1 
IV 
 
24 heifers Ay  11-20  
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Blood samples for progesterone and oestradiol-17β determinations were collected
by vacuum puncture of a tail blood vessel into silicone plain tubes (Venoject,
Terumo Europe N.V., Leuven, Belgium). Samples were taken daily from the day
of PG treatment until ovulation and thereafter on days 1, 2, 3, 5, 7, and 8 or 9.
Serum was harvested, frozen and stored in plastic tubes at -20°C until analysed.
All procedures were performed in the morning from 8:00 to 10:00.
2.2. GnRH during metoestrus (II)
The experiment consisted of two different GnRH treatments (T1, T2) and one
control manipulation (C). Every animal was assigned once to each of these three
manipulations. Oestrus was induced with PG in 18 cases. In 9 cases, oestrus was
induced with an intravaginal device containing 1.9 mg of progesterone and 10 mg
of encapsulated oestradiol benzoate (EAZI-BREEDTM CIDRR device, InterAg,
Hamilton, New Zealand; CidirolR capsules, InterAg, Hamilton, New Zealand).
The device was inserted for 12 days. From the second day after PG or device
removal, the animals were examined daily by transrectal ultrasound to determine
the occurrence of ovulation. After detection of ovulation, the animals were given
250 µg of gonadorelin as follows: 0-24 h after ovulation (T1), 24-48 h after
ovulation (T2), or no gonadorelin (control manipulation, C).
Table 4. Summary of the treatments, ultrasonographic examinations and samplings in Studies I, II, 
III and IV. PG treatments include only treatments given to study manipulations, not for 
synchronisation purposes. 
 
Study PG 
treatment 
 
Timing of GnRH 
treatment after PG 
Ultrasonographic 
examinations 
Sampling 
I 
Prooestrus 
Day 8 or 9 
after 
ovulation 
24 h (Group T24) 
48 h (Group T48) 
72 h (Group T72) 
None (Group C) 
1) plateau phase of 
dominant follicle 
2) ovulation control 
3) days 1 to 9 post-
ovulation 
Blood (serum) 
from PG to day 9 
post-ovulation 
(almost daily) 
II 
Metoestrus 
 After ovulation: 
0-24 h (Group T1) 
24-48 h (GroupT2) 
None (Group C) 
1) ovulation control 
2)   throughout the 
subsequent oestrous 
cycle until next 
ovulation 
Blood (serum) 
from day 1 post-
ovulation to 
next oestrus 
(daily) 
III 
Incidence of 
short cycles 
Day 8 after 
oestrus 
24 h (Group 
PG+GnRH) 
None (Group PG) 
 Whole milk 
from PG to next 
oestrus (daily) 
IV 
Short cycles 
& PGF2α 
Day 6 or 7 
after 
ovulation 
24 h (Groups T) 
None (Groups C) 
1) ovulation control 
2) day 1 to 9 post-
ovulation 
Blood (plasma) 
from PG to day 9 
post-ovulation 
(every 3 h) 
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Ultrasonographic examinations were performed daily from the second day after
PG treatment or device removal until ovulation. After this, examinations were
carried out on days 1, 4 or 5, 7 or 8, 11 or 12, 14 or 15 and daily from the
beginning of the next oestrous signs until ovulation (day 0 = day of ovulation).
Blood samples for progesterone determinations were collected by vacuum
puncture of a tail blood vessel into silicone plain tubes (Venoject, Terumo Europe
N.V., Leuven, Belgium). Samples were taken daily from day 1 after ovulation
until the next oestrus. Serum was harvested, frozen and stored in plastic tubes at
-20°C until analysed. All procedures were performed in the morning, from 08:00
to 10:00.
2.3. Incidence of short oestrous cycles and oestrous signs after GnRH (III)
Eight days after spontaneous oestrus, the cows were palpated per rectum to
determine the existence of a CL, and a new oestrus was induced with PG in the
morning. The animals were divided into two groups by their identification
number. Animals having even numbers were given 100 µg of gonadorelin 24 h
after the PG treatment (PG+GnRH group), while animals having odd numbers
served as controls without any further treatment (PG group). Oestrous signs and
possible metoestrous bleeding were recorded by the herdsmen according to our
instructions. The signs were classified into three categories as follows: clear
signs, weak signs or absence of signs. To minimise subjectivity, the herdsmen
were asked to compare these signs to the signs of the preceding spontaneous
oestrus as follows: weaker, similar or clearer.
Samples of whole milk for progesterone assays were collected into plastic tubes
containing a tablet of sodium azide or bronopol immediately before PG treatment.
Thereafter, daily samples were taken immediately after the morning milking until
the next oestrous signs had been detected for two days. If an animal showed a
short oestrous cycle (less than 16 days), samples were collected daily until the
second oestrus. Milk samples were frozen and stored in original tubes at -20°C
until analysed.
2.4. Short oestrous cycles and 15-ketodihydro-PGF2α (IV)
The animals were allotted to four groups of 6 heifers. In all groups, oestrus was
induced with PG. From the second day after PG treatment, the heifers were
examined daily by transrectal ultrasonography to determine the occurrence of
ovulation. Luteolysis was thereafter induced with the second PG. This was done
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on day 6, 120 to 144 h after ovulation, in 2 groups (groups d6), and on day 7, 144
to 168 h after ovulation, in the other 2 groups (groups d7). Twenty-four hours
after the second PG administration, the heifers of one d6 and one d7 group were
administered 100 µg of gonadorelin to induce premature ovulation (hereafter
named treatment groups T-d6 and T-d7), while the remaining two groups served
as controls without any further treatment (groups C-d6 and C-d7). All injections
were administered at 9:00 a.m.
Transrectal ultrasonographic examinations of the ovaries were performed once
daily (morning) from the day of the second PG treatment and for at least 9 days
after ovulation. On the day of expected ovulation, ultrasonography was repeatedly
performed every 6 h in group T-d6, every 3 h in group T-d7 and every 6 to 12 h in
groups C-d6 and C-d7.
Blood sampling for progesterone and 15-ketodihydro-PGF2α determinations began
from the day of the second PG treatment. The first sample was taken immediately
before PG treatment by vacuum puncture of a tail blood vessel into heparinized
tubes (Vacutainer, Becton Dickinson Vacutainer Systems, Plymouth, UK). After
this, the jugular vein was catheterised with an indwelling catheter (CookR
Veterinary Products V-PPC-7.0U-25, Cook Australia, Queensland, Australia). The
second sample was taken 24 h after the first one, in groups T immediately before
the GnRH treatment. Beginning from the second sample, the heifers were bled
every 3 h, for 9 to 10 days in the T groups and for 11 to 13 days in the C groups.
This scheme allowed blood sampling in all groups for about 9 days postovulation.
After immediate centrifugation (2,500 g, 15 minutes), blood plasma was
harvested, frozen and stored in plastic tubes at -20°C until analysed. During each
sampling, possible oestrous signs and metoestrous bleeding were recorded.
3. Ovarian examinations
In Study III, the ovaries were palpated per rectum to determine the existence of a
CL 8 days after natural oestrus, immediately before the administration of PG. In
Studies I, II and IV, ovarian structures, the growth of the CL and follicles and the
occurrence of ovulation were examined using transrectal ultrasonography (a real-
time B-mode ultrasound scanner, Aloka SSD-210DXII, Aloka,  Japan, equipped
with a 7.5 MHz rectal linear array transducer). All examinations were carried out
by the same operator.
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The ovaries were scanned several times to determine the largest gross-section of
follicles and/or CL. After freezing the image, the largest and the smallest
diameters were measured and recorded, the average diameter was calculated later.
The central cavities of CL were measured and recorded in the same way. All
follicles equal to or larger than 5 mm (Studies I, IV) or 8 mm (Study II) were
measured, whereas those follicles smaller than 5 mm (Study I) or 8 mm (Study II)
were only counted. Locations of follicles larger than 6 mm (equal to or larger than
8 mm, Study II) were coded in order to follow their growth. Occurrence of
ovulation was defined as a sudden disappearance of a large follicle between two
consecutive ultrasound examinations. Day of ovulation (day 0) was determined to
be the last day when the follicle was intact before the examination next day when
the follicle had disappeared.
4. Hormone analyses
4.1. Progesterone
The measurements of blood progesterone concentration were performed by
radioimmunoassay (RIA) by use of a commercial kit (Coat-A-CountR
Progesterone, Diagnostic Products Corporation, Los Angeles, USA). The intra-
assay coefficient of variation for progesterone was 5.8 (Study II) and 6.3% (Study
IV), when calculated from duplicates of measurements between 1.0 and 20.0
nmol/l, and 11.5% when calculated from duplicates of the whole material (Study
I). The inter-assay coefficient of variation varied between 3.6 and 6.7% (I, II, IV).
The detection limit of the assay was 0.3 nmol/l.
In Study III, progesterone concentrations of samples of whole milk were
determined by a microplate ELISA method based on the use of an anti-
progesterone monoclonal antibody (5D4) (Siklodi et al., 1995). The method was
developed and described originally for P4 determination in equine plasma (Nagy
et al., 1998), and was later modified to assay also skimmed (Huszenicza et al.,
1998) and whole bovine milk (Kulcsár M. et al., unpublished data). Shortly
before analysis, the samples were allowed to thaw at room temperature. After
thawing, they were put into a +45°C water bath for 15 minutes and then carefully
shaken for 30 seconds using a single tube vortex in order to redisperse their fat
content. The samples were pipetted into the wells of the microplate immediately
after shaking. All samples were assayed in triplicates in 14 runs, using in total 89
evaluated microplates. Triplicates of standards, as well as of control samples
(stored frozen) with known low (1.71 nmol/l), medium (4.39 and 5.29 nmol/l) and
high (9.42 and 9.93 nmol/l) P4 concentrations, were placed in each microplate.
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The mean (±SD) sensitivity of the assay runs was 0.18±0.05 nmol/l. Depending
on the actual concentrations, the inter- and intra-assay coefficients varied between
10.3 and 12.3%, and between 5.1 and 11.6%, respectively.
4.2. Oestradiol-17β (I)
Oestradiol-17β (E-17β) concentrations were determined by the radioimmuno-
assay procedure previously reported by Sirois and Fortune (1990). The intra-assay
coefficient of variation for E-17β was 4.0% when calculated from duplicates of
the entire material. The inter-assay coefficient of variation was 10.9% (116.3
pmol/l, n=6). The detection limit of the assay was 2.9 pmol/l.
4.3. 15-Ketodihydro-PGF2α (IV)
Prostaglandin F2α secretion was studied as a concentration of its main metabolite,
15-ketodihydro-PGF2α, which was analysed from all plasma samples beginning 24
h after the second PG treatment, according to Granström and Kindahl (1982). The
intra-assay coefficients of variation ranged between 6.6 and 11.7% for the
different ranges of the standard curve and the inter-assay coefficient of variation
was 14%. The detection limit was 75 pmol/l when analysing 0.2 ml plasma.
The basal levels of 15-ketodihydro-PGF2α, the number of pulses, time of their
occurrence and intervals between pulses were calculated during the entire follow-
up period. Peaks of the 15-ketodihydro-PGF2α were identified following the
method described by Zarco et al. (1984), referred to below as a skewness method.
The mean and standard deviation (SD) of all samples were calculated for each
heifer, and values greater than 2 SDs above the mean were arbitrarily considered
to represent a significant elevation, a peak. These values were then eliminated,
and the calculation was repeated until no new peaks were detected. The mean of
the remaining values was considered to represent a mean basal production of 15-
ketodihydro-PGF2α in each heifer, and all values greater than mean basal value
plus 2 SD, peaks, were considered to represent a significant synthesis and release
of PGF2α.
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5. Statistical analysis
The effects of manipulations on progesterone concentrations were analysed by
repeated measures analysis of variance with manipulation and day as within
factors (I, II) and with manipulation as a between factor and day as a within factor
(III, IV). Oestradiol concentrations and diameter, growth and growth rate of the
ovulatory follicles (I), interoestrous intervals and diameter of CL (II) were
analysed by repeated measures analysis of variance with manipulation and/or day
as the within factors. In addition to these, repeated measures analysis of variance,
with group as a between factor and day as a within factor, was used in analysing
the differences in the growths of CL and dominant follicles of the first follicular
waves between the treatment groups as well as between the groups re-allotted
according to cycle lengths (IV). Significance of within effects was evaluated by
use of Greenhouse-Geisser-adjusted P-values.
Analysis of variance was used in testing the differences in the diameters of
ovulatory follicles between treatment and day groups (two-way analysis of
variance, IV) and in the basal levels of 15-ketodihydro-PGF2α between the groups
re-allotted according to cycle lengths (one-way analysis of variance, IV). The
effects of treatment and day on the growth of the dominant follicle and the CL
were studied by covariance analysis (I). The lengths of the two subsequent luteal
phases in cows that showed short cycles (short vs. normal) were analysed by
paired samples t-test (III). The differences in lengths of normal luteal phases
between manipulations were analysed by independent samples t-test (III), as were
the differences in diameter and growth of ovulatory follicle (combined data, I, II,
IV).
The differences in the incidence of short cycles (III, IV), in the intensity of
oestrous signs and in the incidence of metoestrous bleeding (III) between the
manipulations were evaluated by use of a chi-square test. If any of the expected
values in two by two tables was below 5, Fisher’s exact test was used. All
differences were considered significant at P<0.05.
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RESULTS
1. Effect of PG (I, III, IV)
1.1. Luteolytic effect
In this thesis, PG was used in order to induce oestrous periods, during which
prematurely induced ovulations caused by GnRH were studied (I, III, IV). These
PG treatments were always given during early dioestrus or early mid-dioestrus, 6
to 9 days after ovulation.
When PG treatment was administered either on day 8 or day 9 after ovulation (I),
the regression of the CL was rapid and complete in all 36 induced oestrous
periods in 3 cows and 6 heifers, four inductions per each animal. Progesterone
concentration always declined below 2.0 nmol/l within 24 h after the PG
treatment.
In Study IV (IV unpublished data), all animals were heifers, and oestrus was
induced either on day 6 or on day 7 after ovulation. When PG was administered
on day 7, all 12 heifers showed complete luteolysis. In contrast, 3 of 12 heifers
had incomplete luteolysis after the PG treatment administered one day earlier. In
2 of these 3 heifers, P4 concentrations declined in 24 h to 6.9 and 3.8 nmol/l, but
began to rise again, reaching 7.9 and 6.4 nmol/l at 48 h. In the third heifer, signs
of luteolysis were detected in ultrasonography, but P4 concentration remained at
suprabasal level (between 2.6 and 4.8 nmol/l). In the heifers having complete
luteolysis, P4 concentration declined rapidly in most cases: 24 h after the
treatment it was below 3 nmol/l and after 48 h below 1 nmol/l. In one heifer
treated on day 7 (control group), the concentration was 5.6 nmol/l 24 h after
treatment, not falling below 1 nmol/l until 96 h post-treatment. In one heifer
treated on day 6 (treatment group), P4 concentration was 5.1 nmol/l 24 h after
treatment, but the decline continued linearly and fell below 1 nmol/l 48 h after
treatment. Beside these, in one heifer treated on day 6 (treatment group), P4
concentration declined to 1.9 nmol/l within 24 h, but immediately after this, the
concentration began to rise, even before the occurrence of GnRH-induced
ovulation.
In the field study (III), 7 of 60 cows did not respond with luteolysis at all to PG
treatment given on day 8 after oestrus. In 4 cows, the decrease of P4 concentration
was slow, occurring 2 to 5 days after treatment. In addition, 9 cows, 7 in the PG
group and 2 in the PG+GnRH group, developed ovarian dysfunction after
treatment.
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1.2. Effect on ovulation
In all control group animals of Studies I and IV, a large dominant follicle was
present at the time of PG treatment. When treatment was given on day 8 or 9 after
ovulation (I), all animals showed an ovulatory oestrus. Spontaneous ovulations
occurred in 8 animals (2 cows, 6 heifers) between 72 and 96 h, and in one cow
between 120 and 144 h.
When cloprostenol was given on day 7 (IV, IV unpublished data), all 6 heifers
exhibited an ovulatory oestrus after treatment. One heifer ovulated 60 to 72 h,
three heifers 78 to 84 h, one heifer 84 to 96 h and one heifer 108 to 120 h after
treatment. Of the four heifers that showed luteolysis after cloprostenol treatment
given on day 6, only two had an ovulatory oestrus. These heifers ovulated 72 to
96 and 78 to 84 h after treatment.
2. Effect of GnRH on size and growth of ovulatory follicle (I, II, IV)
The diameters of the ovulatory follicles at PG treatment and at ovulation as well
as total growth and growth rate in Studies I, II and IV are presented in Table 5.
When analysing the diameter of the ovulatory follicle during the last 24 h before
spontaneous ovulation, the data of Studies I and II were combined and re-divided
into cows and heifers. Oestruses during which the ovulatory follicles were
followed were induced with PG treatment or a progesterone-releasing intravaginal
device was inserted for 12 days. In Study I, groups T72 and C were combined,
because it is obvious that natural LH release had occurred in most cases before
exogenous GnRH was given 72 h after PG, and thus, GnRH did not have any
effect on the size and growth of ovulatory follicle. The average diameters of
spontaneously ovulated follicles were from 16.9 to 18.5 mm and from 14.5 to
16.6 mm in cows and heifers, respectively. The ovulatory follicles were
significantly larger in cows (P<0.001). The follicles seemed to be somewhat
smaller in Study II than in I and IV.
During the last 24 h before ovulation, the ovulatory follicles were significantly
(P<0.01, IV) or almost significantly (P=0.08, I) smaller when ovulation was
induced with GnRH 24 h after PG as compared to spontaneous ovulations. After
GnRH induction the ovulatory follicle grew significantly less (P<0.05, I; P<0.01,
IV unpublished data) than in control groups due to earlier ovulations. In addition,
there was a significant difference (P<0.05) in the growth rates between groups T
and C (IV unpublished data). Also in Study I, a similar difference was noticed,
although significance was not reached.
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When the dominant follicle of the first follicular wave reached its plateau phase,
its average diameter was 1.0 mm larger in cows than in heifers (P<0.05) (I). This
plateau phase was reached on day 7 or day 8 after ovulation (I). The average
diameter of the dominant follicle in heifers was significantly larger on day 7 than
on day 6 (P<0.05), indicating that growth continued at least until day 7 after
ovulation (IV). On day 7 the dominant follicle probably reached the plateau phase
in Study IV, because the average diameter (13.5±1.7 mm) was about the same
than that in heifers, whose dominant follicle had reached the plateau phase in
Study I (14.1±1.2 mm).
Table 5. Size and growth of ovulatory follicles in Studies I, II and IV. 
 
Study n Diameter at 
PG (mm) 
Diameter at 
ovulation 
(mm) 
Total growth 
(mm) 
Growth rate 
(mm/day) 
Study I      
 Group T24      
  all animals 8 14.7±1.3 15.7±1.4 1.0±1.1 0.5±0.6 
  heifers 6 14.7±1.6 15.2±1.2 0.5± 0.6 0.3±0.3 
 Group T48      
  all animals 8 14.7±0.9 16.1±1.7 1.4±1.1 0.5±0.4 
  heifers 5 14.3±0.6 15.9±1.3 1.6±0.9 0.5±0.3 
 Groups T72+C      
  all animals 17 14.1±1.4 16.6±1.6 2.6±1.0 0.9±0.3 
  heifers 12 13.7±1.1 15.9±0.9 2.2±0.7 0.7±0.2 
  cows 5 15.1±1.5 18.5±1.5 3.4±1.0 1.1±0.3 
      
 all animals 33 14.4±1.3    
 heifers 23 14.1±1.2    
 cows 10 15.1±1.2    
      
Study II      
 all animals 25  15.4±2.2   
 heifers 16  14.5±2.0   
 cows 9  16.9±1.9   
      
Study IV      
 Groups d6 8 11.8±1.1 14.0±2.5 2.2±1.9 0.9±0.7 
 Groups d7 12 13.5±1.7 15.8±1.2 2.3±1.7 0.9±0.6 
 Groups T 12 12.7±1.6 14.0±1.7 1.3±1.2 0.7±0.6 
 Groups C 8 12.9±1.9 16.6±1.3 3.7±1.5 1.2±0.4 
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3. Effect of GnRH on oestradiol-17β during PG-induced oestrus (I)
On the day of PG treatment, 8 or 9 days after ovulation, during the non-growing
phase of the dominant follicle, the concentration of E-17β was low, less than 9.5
pmol/l, in all animals during every manipulation period. This was followed by a
rapid rise within 24 h after PG administration. This rise continued at a slower rate
until 48 h in groups T48, T72 and C. In group T24, where GnRH was given 24 h
after PG treatment, the concentration had dropped back to basal level, causing a
significant difference in E-17β concentration between T24 and C at 48 h
(P<0.001). The other treatments did not differ from control. In all treatment
groups, E-17β concentration was approximately at basal level 24 h after GnRH
treatment.
4. Ovulations induced with GnRH (I, III, IV)
Premature ovulations were induced by GnRH treatment in Studies I, III and IV.
When GnRH was administered either 24 h or 48 h after PG treatment (I), induced
ovulation occurred in 16 of 18 cases 24 h to 48 h after GnRH administration. In
one case, the dominant follicle of a cow continued to grow for 6 days despite
GnRH administration and lost its dominance after that. In another case, the
emergence of a subsequent follicular wave was detected at the time of GnRH
treatment.
With more frequent (3 to 6 h) ultrasound scanning (IV), time intervals between
GnRH treatment and ovulation were as follows: 24 to 27 h in 6 heifers, 24 to 30 h
in 5 heifers and 30 to 36 h in one heifer. All animals ovulated in response to
GnRH treatment.
In the field study (III), day of ovulation (day 0) was estimated based on the rise of
P4, because no ultrasound examination was used. The day when P4 concentration
exceeded 1 nmol/l for the first time was found to be day 3. In most cases this was
also in close accordance with the behavioural signs of oestrus. Thus, ovulations
occurred approximately 1.8 days after GnRH treatment. However, in some cases
ovulation seemed to take place as late as 4 to 5 days after GnRH treatment.
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5. Effect of GnRH administered during PG-induced prooestrus
5.1. Effect on oestrous cycle length (I, III, IV)
Length of oestrous cycle following GnRH-induced ovulation was estimated using
detection of oestrous signs, progesterone profiles (I, III, IV) and ultrasound
scanning (I, IV). When ovulation was induced with GnRH treatment during early
prooestrus 24 h after PG administration, the subsequent oestrous cycle was
clearly shortened in some animals. In Study I, of eight animals (2 cows, 6 heifers),
one heifer and one cow ovulated 9 (cow) and 10 (heifer) days after induced
ovulation. The animals also showed behavioural signs of oestrus and an increased
uterine tone at rectal palpation in connection with these ovulations. No premature
luteolyses were detected in control animals as well as in those animals treated
with GnRH 48 h or 72 h after PG administration.
In Study IV, some heifers had a premature decline in P4 concentration. All of these
heifers showed behavioural signs of oestrus, or at least typical vaginal discharge,
for some days after the decline. The duration of the oestrous cycles was
calculated from the day of GnRH treatment (one day before ovulation) to the
subsequent spontaneous behavioural signs of oestrus. Ovulation during this
oestrus was followed by ultrasonography, and the duration of these cycles was
also calculated from the GnRH-induced ovulation to the subsequent ovulation.
Durations of oestrous cycles after the PG+GnRH treatments from GnRH to the
subsequent oestrus, from an ovulation to the subsequent ovulation, and in the case
of a short oestrous cycle, duration of the subsequent cycle in groups T-d6 and T-
d7 are presented in Table 6. Seven short oestrous cycles, 8 to 12 days in duration,
were detected among 12 treated cycles, while no short cycles were found in 8
control cycles. The difference in the incidence was statistically significant
(P<0.05). The incidence of short cycles after PG and GnRH administrations 24 h
apart was 58% (95% confidence interval 30% to 86%).
In the field study (III), ovulation was not monitored, but lengths of oestrous
cycles were assessed based on P4 profiles. Luteal phase was defined to be the
interval during which P4 concentration of whole milk exceeded 1 nmol/l as
determined by the ELISA method described in Section 4.1. When the luteal phase
was shorter than 10 days, the oestrous cycle was called a short cycle. No short
cycles were observed in the control group, whereas four of twelve cows treated
with PG+GnRH showed a short oestrous cycle (P<0.05). The incidence of short
cycles was 33% (95% confidence interval 6 to 60%). The length of the short
luteal phases varied from 3 to 6 days with an average of 4.0±1.4 days. The
approximated length of these short cycles was 8 to 10 days. The next luteal
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phases during the subsequent untreated oestrous cycles were significantly longer
(P<0.001) than the short ones, with an average of 18.0±2.0 days. The lengths of
the luteal phases after treatments in the control group and in those cows treated
with PG+GnRH but having normal cycles were 15.9±2.3 and 17.1±4.6 days,
respectively. There were no differences between the means, but the variance in
the latter group was significantly larger (P<0.05). After GnRH-induced ovulation,
in addition to the short cycles, some “normal” cycles seemed to be lengthened.
5.2. Effect on progesterone concentration (I, III, IV)
Significant differences in P4 concentrations were detected between treatment and
control groups (III, IV). After GnRH-induced ovulation, the concentration
remained at a lower level from day 5 onwards (Study IV, group T-d6, P<0.01),
from day 7 (Study IV, group T-d7, P<0.05) or from day 8 (Study III, P<0.05) than
in control groups. In Study I, however, no significant differences were detected,
although the daily rise in P4 concentration seemed to be slower in group T24.
Evaluating the individual progesterone profiles, it becomes obvious that the
arrested rise in group averages of P4 concentration in the treatment groups is
caused by a bipartite reaction of the individuals (I, III, IV). As explained in
Section 5.1., some animals showed a short oestrous cycle after prematurely
Table 6. Durations of oestrous cycles after cloprostenol (0.5 mg, i.m.) and GnRH (100 µ  g, i.m.) 
treatments 24 h apart from GnRH treatment to subsequent oestrus, and in case of short oestrous 
cycle, from ovulation to subsequent ovulation, and duration of subsequent cycle in groups T-d6 
(cloprostenol given on day 6 after ovulation) and T-d7 (cloprostenol given on day 7 after ovulation). 
 
Heifer Duration of the cycle, in days Duration of the  
 GnRH to next 
oestrus 
Ovulation to next 
ovulation 
next cycle, in days 
Group T-d6    
221 22   
223 21   
225 12 12 18 
226 9 anovulation - 
228 10 9 20 
941 10 anovulation - 
Group T-d7    
229 9 9 19 
231 23   
232 18   
234 18   
235 9 9 18 
240 9 8 19 
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induced ovulation. For further analysis, the animals in the treatment groups were
re-divided into those with a short cycle (group TS) and those with a normal cycle
(group TN) (In Article III, group TS is called SGS and group TN is called SGN.)
(III, IV). No significant differences in P4 levels and profiles of P4 curves were
found between group TN and the control group (III, IV), while the P4 curve of
group TS was significantly different (P<0.001) from that of the control group. No
differences in P4 levels could be detected during the first 5 days after ovulation,
but from day 6 onwards the concentration declined rapidly in group TS (III, IV).
In individuals (IV), the highest P4 concentration was attained on day 5 after
ovulation in four of seven heifers. In two heifers, the highest concentration
occurred on day 4; however, in these heifers, the P4 concentration did not decline
below 1 nmol/l, but remained at suprabasal levels, around 2 and 3 nmol/l, during
the entire sampling period after the decline (i.e. 6 to 7 days). In one heifer, the
concentration remained more or less unchanged for 4 days, between days 5 and 8,
and was then followed by a sudden decline.
5.3. Effect on corpus luteum (I, IV)
Diameters of corpora lutea among the treatment and control groups were analysed
from day 3 (I) or from day 4 (IV) to day 8 after ovulation. Significant differences
in the growth profiles of corpora lutea were found in Study IV (IV unpublished
data) between groups T-d6 and C (P<0.05) as well as between T-d7 and C
(P<0.05). In Study I, however, no differences were found. For further analysis in
Study IV, the heifers of the treatment groups were re-allotted into groups TS and
TN, as was done in the analysis of P4 concentrations. The mean estimated growth
rates of CL from day 4 to day 8 were –0.2±0.8, 1.5±0.5, and 1.8±0.6 mm/day in
groups TS, TN, and C, respectively. No significant differences in diameter or
growth of CL were found between groups TN and C. However, the development
of CL in group TS was significantly different from that in group C (P<0.001). In
group TS, the growth and diameter of CL were similar to those in groups TN and
C until day 5, but thereafter, the growth ceased and the diameter began to
decrease.
5.4. Effect on follicular growth after induced ovulation (I, IV)
The growth pattern of the dominant follicle of the first follicular wave following
GnRH-induced ovulation was not significantly different from that following
spontaneous ovulation (I, IV). The mean estimated growth rates after spontaneous
ovulations were 1.5±0.4 (from day 2 to day 7, I) and 1.5±0.4 mm/day (from day 2
to day 6, IV). After GnRH-induced ovulations they were 1.3±0.2 mm/day
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(PG+GnRH 24 h apart, from day 2 to day 7, I), 1.6±0.3 mm/day (PG+GnRH 48 h
apart, from day 2 to day 7, I), and 1.3±0.2 (PG on day 6+GnRH 24 h apart, from
day 2 to day 6, IV) and 1.2±0.3 (PG on day 7+GnRH 24 h apart, from day 2 to
day 7, IV).
However, a significant difference was observed in the levels of the growth curves
between groups T24 and C (P<0.01, I) as well as between groups T-d7 and C
(P<0.05, IV). The follicles in groups T24 and T-d7 were on average 1 to 2 mm
larger than in the control groups throughout the growth period. No differences
were found, however, between groups T48 and C (I) and between T-d6 and C (IV
unpublished data). The appearance of a short oestrous cycle did not seem to have
any influence on the size of the dominant follicle, or vice versa, since no
differences were found between groups TS, TN and C (IV).
6. Effect of GnRH given during metoestrus (II)
6.1. Effect on follicles and corpus luteum
On day 1 (0-24 h after ovulation), follicles larger than 8 mm were found in four
instances, twice in group T1, once in group T2 and once in group C. As GnRH
treatment did not induce ovulation of larger or smaller follicles, no accessory
corpora lutea were found later.
Corpus luteum size was analysed on day 11 or 12 and day 14 or 15 after
ovulation, and the results are presented in Table 7. In group T1, on day 14 or 15,
CL was on average 1.3 mm smaller than in group C (P<0.01), but no significant
differences were found on day 11 or 12, nor between groups T2 and C.
6.2. Effect on progesterone patterns
A significant effect of day was observed on P4 concentration in all manipulations
(P<0.001). On day 3, P4 concentration began to rise steadily until day 11, with P4
levels remaining unchanged thereafter. The mean estimated daily rise in P4
concentration from day 2 to day 11 was 1.8±0.5 nmol/l. The group averages are
presented in Table 7. No significant differences were found in levels or profiles of
P4 curves between GnRH treatments and control manipulation.
In group C, P4 concentration rose continuously from day 2 to 11, but a slight
decline in P4 concentration was noticed in GnRH treatments between days 7 and 8
after ovulation in group T1, and between days 8 and 9 in group T2. In both
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treatment groups (T1 and T2), the decline occurred between days 6 and 7 after
GnRH administration. In individual animals, this decline occurred in 8 of 9
animals in groups T1 and T2, and in 2 of 9 in group C between days 5 and 9 after
ovulation. The decline occurred in six cases between days 7 and 8 in group T1; in
group T2 the decline was more inconsistent.
During the last 8 days before the next ovulation, a significant decline in P4
concentration was detected between days -4 and -3 (P<0.01) in groups T1, T2 and
C. There were no significant differences in the levels or profiles of P4 curves
during these days between GnRH treatments and control manipulation.
6.3. Effect on oestrous cycle length
The length of the oestrous cycle in groups T1, T2 and C was 21.9±1.8, 22.3±2.1
and 21.6±1.8 days, respectively. GnRH treatment given on day 1 or 2 after
ovulation did not have any significant effects on inter-oestrous intervals. Instead,
the animal effect was significant on the mean length of the oestrous cycle
(P<0.01).
7. Short oestrous cycles and PGF2α secretion (IV)
The P4 and 15-ketodihydro-PGF2α profiles of heifers 225, 226 and 228, of heifers
229, 235 and 240, as well as of heifers 231, 234 and 239 are illustrated in Figures
4, 5 and 6, respectively. The basal levels of 15-ketodihydro-PGF2α during the
entire follow-up period were 188±61 pmol/l (min 106, max 297), 147±33 pmol/l
(min 111, max 200) and 141±36 pmol/l (min 100, max 214) in the treatment
group heifers with a short and a normal oestrous cycle and in the control group
heifers, respectively. Heifer 228 in group TS had a divergently high basal level,
297 pmol/l. If it was removed from the results, the basal level in group TS was
Table 7. Size of CL on days 11 or 12 and 14 or 15, and daily rise in P4 concentration from day 2 to 
day 11 after ovulation, when GnRH (250 µg, i.m.) was administered 0 to 24 h (T1) and 24 to 48 h 
(T2) after ovulation, or when no GnRH was given (C). 
 
 T1 T2 C 
Diameter of CL, mm    
 Day 11/12 22.2±2.0 22.7±3.2 22.7±3.2 
 Day 14/15 21.2±2.0a 22.1±2.9 22.6±2.0 
P4 concentration, nmol/l    
 Daily rise, D2 – D11 1.9±0.6 1.8±0.4 1.7±0.5 
 
a Significantly different from control (P<0.01) 
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Figure 4. Peripheral blood plasma progesterone ( ? ) and 15-ketodihydro-PGF2α ( ) 
concentrations in heifer nos. 225, 226 and 228, which showed a short oestrous cycle after
cloprostenol (0.5 mg, on day –2) and GnRH (100 µg) treatment 24 h apart. The horizontal line 
denotes the line of significance (mean basal value + 2SD) for 15-ketodihydro-PGF2α concentrations. 
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Figure 5. Peripheral blood plasma progesterone ( ? ) and 15-ketodihydro-PGF2α ( ) 
concentrations in heifer nos. 229, 235 and 240, which showed a short oestrous cycle after
cloprostenol (0.5 mg, on day –2) and GnRH (100 µg) treatment 24 h apart. The horizontal line 
denotes the line of significance (mean basal value + 2SD) for 15-ketodihydro-PGF2α concentrations. 
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Figure 6. Peripheral blood plasma progesterone ( ? ) and 15-ketodihydro-PGF2α ( ) 
concentrations in heifers nos. 231, 234 and 239. Heifer nos. 231 and 234 were treated with
cloprostenol (0.5 mg, on day –2) and GnRH (100 µg) 24 h apart, while heifer no. 239 was treated
with cloprostenol (0.5 mg, on day –4), but no GnRH was given.   All  heifers had oestrous cycles of
normal length. The horizontal line denotes the line of significance (mean basal value + 2SD) for 15-
ketodihydro-PGF2α concentrations. 
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170±41 pmol/l (min 106, max 216). No significant differences in the basal levels
of 15-ketodihydro-PGF2α were found among the groups, with or without heifer
228.
After P4 exceeded 3 nmol/l (day 2 or 3, heifer 228 day 0, heifer 224 day 1),
significant elevations in 15-ketodihydro-PGF2α concentrations were detected in all
heifers that showed short oestrous cycles (group TS), but not in any heifers with
normal oestrous cycles (group TN) in groups T. The pattern of significant
elevations of 15-ketodihydro-PGF2α concentrations in heifers in group TS,
number of peaks, intervals from ovulation to the first peak and intervals between
the peaks are presented in Table 8. Some of these peaks, the first one in heifer 228
and the first two in heifer 235, were fairly low, exceeding the level of significance
by not more than 12 pmol/l. In group C, significant elevations in 15-ketodihydro-
PGF2α concentrations were detected in 4 heifers (222, 224, 244 and 246). In
heifers 222, 224 and 244, a low single peak was seen around day 3 or 4. In heifers
222 and 224, two peaks and in heifer 246 one peak was detected during day 9.
None of these peaks exceeded the level of significance by more than 35 pmol/l,
except in heifer 222 on day 9, 141 pmol/l. However, neither this nor any of the
other peaks seemed to have any influence on P4 concentration.
8. Oestrous signs during PG-induced oestrus with or without GnRH-induced
ovulation (III)
The intensities of oestrous signs in both PG and PG+GnRH groups are shown in
Table 9. After PG-only treatment, 30 of 35 cows showed oestrous signs of varying
intensity. Of those animals that really were in ovulatory oestrus (P4<1 nmol/l), all
except one showed oestrous signs. Oestrous signs after the PG+GnRH treatment
were significantly weaker than those observed after the PG treatment (P<0.001).
In the PG+GnRH group, none of the cows in ovulatory oestrus showed clear
oestrous signs, and 10 of 13 did not exhibit any signs at all.
The intensity of oestrous signs after the treatments was also compared to those of
the signs observed during the previous spontaneous oestrus. After the PG-only
treatment, no differences in intensity were found, either among all cows, or
among those that really were in ovulatory oestrus. Thus, PG had no effect on the
intensity of oestrous signs. On the other hand, GnRH treatment 24 h after PG
treatment weakened the oestrous signs significantly (P<0.01).
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After spontaneous oestrus, the incidence (±SEM) of metoestrous bleeding was
57±6%. It can be expected that the accuracy in detecting vaginal discharge
decreases when cows are grazing. When the period on pasture is removed from
the analysis, the incidence (±SEM) of metoestrous bleeding was 64±7%. After
PG-only treatment, 8 of the 21 cows that were really in oestrus showed bloody
discharge, whereas 11 of these animals had displayed metoestrous bleeding after
the previous spontaneous oestrus. Thus, PG did not have any significant influence
on metoestrous bleeding. After PG+GnRH treatment, none of the animals showed
bloody discharge.
Table 8. Significant elevations in 15-ketodihydro-PGF2α as indicated by number of peaks, interval 
from ovulation to first peak and intervals between peaks, during a period of high P4 in the heifers 
that showed short oestrus cycle (group TS). Values of 15-ketodihydro-PGF2α were considered 
significantly elevated when they exceeded mean basal value +2SD as calculated by skewness 
method. 
 
Heifer Number 
of peaks 
Interval from 
ovulation to 
Intervals between peaks, h Complete 
luteolysis 
  1st peak, h 1.-2. 2.-3. 3.-4. 4.-5. 5.-6. 6.-7.  
          
225 7 96 9 24 21 33 18 9 yes 
226 4 105 9 9 9    no 
228 5 75 66 9 9 6   yes 
229 5 151 15 6 9 6   yes 
235 7 88 24 15 18 9 9 15 yes 
240 4 103 21 9 9    yes 
941 5 99 15 15 15 15   no 
 
Table 9. Intensity of oestrous signs of all cows and cows in ovulatory oestrus in PG and PG+GnRH 
groups. In both groups, cloprostenol (0.5 mg, i.m.) was given 8 days after oestrus. In the PG+GnRH 
group, gonadorelin (100 µg, i.m.) was administered 24 h after cloprostenol treatment, while no 
further treatment was administered to the PG group. 
 
 PG group PG+GnRH group 
 all cows (n) cows in oestrus 
(n) 
all cows (n) cows in oestrus (n) 
 
Total cows (n) 
 
35 
 
21 
 
25 
 
13 
Oestrous signs     
 Clear 24 17 2 0 
 Weak 6 3 10 3 
 None 5 1 13 10 
Comparison to previous signs 
of spontaneous oestrus 
  
 
 Clearer 8 7 2 1 
 Similar 13 8 4 1 
 Weaker 9 5 6 1 
 None 5 1 13 10 
 
53
kirjavalmis5.pmd 2.7.2003, 10:1055
DISCUSSION
1. Effect of PG
Prostaglandin F2α and its agonists cause luteolysis very effectively, resulting in a
premature new oestrus and ovulation. When PG treatment was administered
either on day 8 or day 9 after ovulation to cows and heifers (I), or on day 7, 144 to
168 h after ovulation – that is, 7 to 8 days after oestrus – to heifers (IV), all
animals were in oestrus within 6 days after the treatment, as expected. By
contrast, this was not the case in Study III, where PG was administered to cows
on day 8 after oestrus. As P4 did not decline in 7 of 60 cows (III), CL did not
regress after PG treatment, and the animals returned to oestrus 18 to 25 days after
the preceding oestrus. The luteolytic potency of PG is dependent on the stage of
the luteal phase. During early dioestrus, PG is less effective in inducing
regression of the CL than later (King et al., 1982, Wiltbank et al., 1995). In
lactating dairy cows, no luteolytic response to PG was observed during the first 5
days after oestrus, but on days 6 and 7 after oestrus, a 25% and 66% response,
respectively, and greater than 90% response thereafter has been shown (Seguin,
1997; Wiltbank, 1997). In heifers, responsiveness to PG is regained somewhat
earlier than in cows (Seguin, 1997; Wiltbank, 1997). On day 5 after oestrus, 41%
of heifers responded to PG treatment with luteolysis (Wiltbank, 1997). Because
the day of oestrus was determined by detection of external oestrous signs in Study
III, there may be a variation of about ± 1 day in the day of cycle. This variation
could explain the high incidence of unresponsiveness to PG, and other ovarian
dysfunctions seen in this study. Also in Study IV, when PG was administered to
six heifers on day 6, 120 to 144 h after ovulation, three animals had incomplete
luteolysis and one animal did not ovulate. Similar failures in oestrus
synchronisation during early dioestrus, after day 4, were shown by King et al.
(1982). These findings indicate that the oestrus synchronisation effects of PG on
day 7, and maybe also on day 8 after oestrus in cows, and one day earlier in
heifers, could be poor. Thus oestrus synchronisation should be avoided on these
days, whenever possible.
The slow decrease in P4 concentrations after PG administration seen in some
animals in Studies III and IV is not in accordance with many earlier findings.
After PG treatment, P4 concentration has been reported to start to decrease in 10
min (Hafs et al., 1974; Oxender et al., 1974). A reduction in P4 concentration by
about 60% within 12 h (Louis et al., 1973), less than 3.2 nmol/l by 24 h (King et
al., 1982), and a plateau 48 to 72 h (Stellflug et al., 1975) after PG treatment has
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been documented. The slow decrease, like some other disturbances, may be
related to the early administration of PG during a time when CL was still
completely or partially refractory to PGF2α.
The interval from PG treatment to spontaneous ovulation can be studied in the
control groups of Studies I and IV. Eight of the 9 animals (2/3 cows, 6/6 heifers)
(I) and 6 of the 8 heifers (IV) ovulated 72 to 96 h after PG administration. The
mean interval to ovulation has been reported to vary from 79 to 104 h (Hafs et al.,
1974; Oxender et al., 1974; Cooper, 1974; Wishart, 1974). However, it seems to
depend on the stage of dioestrus when administration occurs. It is about half a day
shorter during early than during late dioestrus, and about half a day shorter in
heifers than in cows (King et al., 1982). More precisely, the mean response
intervals are longer among cows treated around mid-dioestrus and shorter for
early and late dioestrus (Macmillan and Henderson, 1984). The time of onset of
oestrus is dependent on the stage of the follicular wave when CL regression is
induced. The interval is shortest when a mature dominant follicle is present at PG
administration, and longest when a follicle wave is emerging or undergoing
selection (Roche et al., 1996). When PG was administered on day 8 after
ovulation in heifers, the mean time interval between treatment and ovulation was
89 h (Kastelic et al., 1990a). Following two cloprostenol treatments 11 days apart
in heifers, ovulation had not begun within 72 h, while 95% had ovulated within
96 h (Roche, 1977). In Roche’s study, the second treatment was given
approximately 6 to 8 days after ovulation, which is close to the time point in
Study IV. In Study I, the treatment was given 8 or 9 days after ovulation, but this
probably should not have caused any difference, because the time of treatment
was fixed to the early static phase of the dominant follicle. Thus, our findings are
in good accordance with their reports. In the heifer that ovulated 108 to 120 h
after PG treatment, P4 concentrations did not fall below 1 nmol/l until 96 h after
the PG treatment. Thus, a slow decrease in P4 concentration seems, at least in
some cases, to affect the interval from PG administration to oestrus and ovulation.
2. Effect of GnRH on size and growth of the ovulatory follicle
The mean maximum diameter of the ovulatory follicle during the last 24 h before
ovulation in heifers was 14.5 to 16.6 mm. This is in good agreement with the
earlier reports: between 15.3 and 20.3 mm in two-wave cycles and between 12.8
and 18.6 mm in three-wave cycles after natural luteolysis (Savio et al., 1988;
Sirois and Fortune, 1988; Knopf et al., 1989; Ginther et al., 1989a; Ginther et al.,
1989b) and between 13.7 and 19.5 mm after PG-induced luteolysis (Kastelic et
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al., 1990a; Kastelic and Ginther, 1991). Much less information is available about
follicles in cows. Our results indicate that ovulatory follicles are 2 to 2.5 mm
larger in cows than in heifers.
It has been reported that the dominant follicle of the first wave reaches its
maximum diameter on day 7 after ovulation (Knopf et al., 1989), or between days
6 and 7 (Ginther et al., 1989a; Ginther et al., 1989b) in heifers. In Studies I and
IV, the growth phase seemed to be slightly (0.5 to 1 day) longer. The mean
maximum diameter of the dominant follicle in heifers has varied between 15 and
18 mm (Savio et al., 1988; Knopf et al., 1989; Ginther et al., 1989a; Ginther et al.,
1989b; Kastelic et al., 1990a; Kastelic and Ginther, 1991; Bodensteiner et al.
1996), which is somewhat larger than our findings (mean 14.1 mm, range 11.5 to
16.5 mm). Only Savio et al. (1988) in two-wave cycles, and Sirois and Fortune
(1988), have reported smaller diameters, 14 and 12 to13 mm, respectively. As is
the case for ovulatory follicles, little information about dominant follicles in cows
is available. As earlier observations suggest (Kastelic et al., 1990a; Kastelic and
Ginther, 1991), the static-phase dominant follicle, though it has apparently
reached its natural maximum diameter, is capable of further growth after induced
luteolysis. Growth of the ovulatory follicle and linear growth rate from PG
treatment to ovulation were consistent with findings of Kastelic et al. (1990a) and
Kastelic and Ginther (1991).
Early induction of ovulation (24 h after PG treatment) with GnRH led to a smaller
total growth of a dominant follicle and a smaller follicle at ovulation. In addition,
the follicular growth rate was slower after GnRH treatment, possibly indicating
that GnRH retards follicular growth. Although the mean diameter of the ovulatory
follicle at ovulation was smaller in the GnRH-treated groups than in the control
groups due to earlier ovulations induced with GnRH, the sizes of ovulatory
follicles were within the range of normal ovulatory follicles during induced and
spontaneous oestrus described above. Hence, it is obvious that the size and
growth of the ovulatory follicle provide sufficient capacity for further normal
development after ovulation.
3. Effect of GnRH on oestradiol-17β during PG-induced oestrus
On the day of PG treatment, 8 or 9 days after ovulation, the concentration of
oestradiol in all animals in every treatment was at the basal level. This is
consistent with reports from Glencross and Pope (1981) and Dieleman et al.
(1986). Luteolysis caused by PG treatment was followed by a rapid rise in
oestradiol concentration. A peak value was reached 48 h after the treatment when
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GnRH was given 48 h or later after PG (groups T48, T72, C). The time to peak
value was similar to that shown by Dieleman et al. (1986) in natural luteolysis,
but one day shorter than that observed by Glencross and Pope (1981) after PG-
induced luteolysis. Glengross and Pope administered PG later in the oestrous
cycle, when newly recruited follicles were in the growth phase, which may
explain the difference.
In group T24, when GnRH was administered 24 h after PG treatment, oestradiol
concentrations failed to continue to rise after day 1 as in other treatments, but
reached a peak value 24 h after PG administration. This was followed by a
precipitous decline to the basal level during the following 24 h. A similar fall was
seen in other treatments and control after 48 h post-treatment. It has been shown
that the LH surge inhibits oestradiol secretion of the preovulatory follicle
(Dieleman et al., 1986), and the amount of GnRH used in this study causes an LH
surge (Chenault et al., 1990). The decline in oestradiol to the basal level occurs in
24 h, as reported by Dieleman et al. (1986). Duchens et al. (1994) found a slower
decline during 48 h, but this was probably due to less frequent sampling. The fall
in oestradiol concentration between 48 and 72 h in Study I can be explained by a
natural LH surge in groups T72 and C. In group T48, it may have been caused
either by a natural or by a GnRH-induced LH surge. When GnRH was
administered 24 h after PG treatment, it seemed to cause an LH surge, which
stopped the oestradiol secretion of the preovulatory follicle. This occurred
although the follicle had not reached final maturity, as in other treatments.
4. Ovulations induced with GnRH
One hundred µg of gonadorelin given during early dioestrus caused ovulation
very effectively in 16 of 18 (I) and in 12 of 12 animals (IV). As detected by
frequent ultrasound scanning (IV), 11 of 12 heifers ovulated 24 to 30 h, and one
30 to 36 h, after treatment. This accords well with earlier findings that GnRH
causes ovulation between 24 and 32 h after treatment when a dominant follicle is
present (Pursley et al., 1995). In Study III, the approximate time of ovulation was
1.8 days (about 43 h) after GnRH treatment. Hence, it is obvious that in some
animals GnRH did not cause ovulation, possibly due either to an inadequate dose
of GnRH or to the fact that the follicle had lost its dominance. In some animals,
however, ovulation seemed to occur as late as 4 to 5 days after GnRH treatment,
which suggests that the dose of 100 µg may be inadequate, at least in cows.
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5. Effect of GnRH administered during PG-induced prooestrus
When GnRH was given 24 h after PG treatment, some animals exhibited a short
oestrous cycle. In all the 35 control cycles, the length of the oestrous cycle was
normal, but the incidences of short cycles were 25%, 33% and 58% in Studies I,
III and IV, respectively. In Studies III and IV, the difference in the incidence was
statistically significant. Similar findings have been reported by Stevens et al.
(1993), when GnRH was administered simultaneously with PG. Significantly
lowered pregnancy rates after timed AI have been detected following GnRH
injection 24 h after PG (Schmitt et al., 1996).
Because ultrasound follow-up was not used in Study III to confirm complete
luteal regression following PG treatment, occurrence of ovulation after GnRH
treatment, and formation of a new CL, we cannot be absolutely sure that the
detected short cycles were real oestrous cycles with ovulation and CL formation.
GnRH administration 12, 24 and 48 hours after PG treatment has been shown to
result in increased P4 concentrations, suggesting either rescue or stimulation of
the CL (Thatcher and Chenault, 1976). The increase was, however, small and the
duration only a few hours. In theory, the administration of GnRH could have
rescued luteal tissue, and this original luteal tissue might have regressed at the
end of the initial oestrous cycle, resembling a short oestrous cycle. In all cases of
short cycles, P4 concentrations declined to the basal levels and remained there for
at least 4 days. In the case of rescued luteal tissue, the decline in P4 concentrations
should have been shorter in duration. Thus, it is obvious that regression of a CL,
ovulation and formation of a new CL occurred after the treatments followed by
the short cycles described here, as we have seen in Studies I and IV, where
ultrasound examinations were used to confirm ovarian function.
Short oestrous cycles have been studied widely. Premature luteolysis shortening
the normal length of the bovine oestrous cycle is a common phenomenon
following the first ovulation during puberty or following first spontaneous or
gonadotropin-induced ovulations postpartum [for reviews see: Garverick and
Smith, (1986); Hunter, (1991); Lishman and Inskeep, (1991); Garverick et al.,
(1992)]. Most studies have been performed with suckled beef cows, because the
first postpartum ovulation after early weaning of calves (30 to 35 days of age) is
normally followed by a short luteal phase. In dairy cows as well, a higher
incidence of short oestrous cycles has been observed after first postpartum
ovulations (Kesler et al., 1979; Hinshelwood et al., 1982; Peter et al., 1989). Odde
et al. (1980) reported that among short cycles, duration of 7 to 10 days was
common, but 8 days duration was the most frequent.
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Most studies investigating mechanisms associated with subnormal luteal function
have utilised the model of CL formed following the first induced or spontaneous
ovulation postpartum. In theory, the mechanisms behind the short oestrous cycles
may include: (1) inadequate preovulatory follicular development, (2) decreased
luteotropic support, or (3) premature release of a luteolysin [for reviews see:
Garverick and Smith, (1986); Hunter, (1991); Lishman and Inskeep, (1991);
Garverick et al., (1992)]. While the mechanisms are not yet fully understood,
recent findings indicate that early demise of the CL is the result of premature
release of PGF2α from the uterus (Copelin et al., 1987; Lishman and Inskeep,
1991; Garverick et al., 1992). When postpartum cows were hysterectomized prior
to the first ovulation, CL were maintained, and secretion of P4 was similar to that
observed during a normal oestrous cycle (Copelin et al., 1987). Armstrong and
Hansel (1959) have shown that daily administration of oxytocin during the first
week after oestrus results in shortened oestrous cycles (8 to 12 days). In cows
exhibiting subnormal luteal function, the uterus has a greater potential to release
PGF2α in response to oxytocin earlier during the oestrous cycle than in cows
exhibiting normal luteal function (Zollers et al., 1989). The luteolytic effect on
CL appears by day 6 after the first oestrus (Copelin et al., 1987). During short
oestrous cycles, there are more oxytocin receptors and fewer progesterone
receptors in the endometrium, which may explain the greater response to oxytocin
(Zollers et al., 1989; Zollers et al., 1993). Progestagen pretreatment prevents
premature luteolysis, but it is unclear whether its effect on PGF2α secretion is
indirect or direct (Ramirez-Godinez et al., 1981; Sheffel et al., 1982; Garverick et
al., 1992).
The short oestrous cycles described in this study occurred in normally cycling
animals having a luteal phase immediately prior to the short cycle. Thus, there
seems to be a difference between the short cycles described here and those
occurring after the first ovulation postpartum. We have shown (IV) that the luteal
regression seen in these short cycles is caused by a premature release of PGF2α.
But why PGF2α is released prematurely remains to be elucidated. Quintal-Franco
et al. (1999) have shown that episodic release of LH pulses before, during and
after the time of a preovulatory LH surge may stimulate CL development and
function. Compared with those in control animals, P4 concentrations were less
and diameters of CL smaller in animals in which LH release was inhibited by
treatment with an antagonist. However, during the short cycles described here, no
differences were found in the size of CL or P4 concentrations before the onset of
premature luteal regression.
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6. Effect of GnRH administered during metoestrus
In 4 of 27 cases, a follicle larger than 8 mm was detected during the first 24 hours
after ovulation. These follicles were most probably regressing dominant follicles
from the preceding anovulatory follicle waves, as can be seen from the studies of
Ginther et al. (1989a) and Knopf et al. (1989). None of these follicles ovulated
after GnRH treatment, which confirms their suggested atretic nature.
Kastelic et al. (1990b) have shown that the correlation between the size of CL and
plasma P4 concentration is between 0.7 and 0.8. Thus, the size of CL can be used
as a method for assessment of luteal function. In our study, the difference of 1.3
mm in the diameter of the CL on day 14 or 15 between groups T1 and C was
statistically significant, implying a difference of about 20% in spherical volume.
The difference is, however, so small and close to the precision of measurement
that its practical significance may be questionable.
Although there were no significant differences in levels or profiles of P4 curves
between GnRH and control treatments in our study, a slight decrease in P4
concentrations was noticed in group T1 beginning from day 8 and in group T2
from day 9 (7 days after the GnRH administration), but not in group C. This
finding is in agreement with the results reported by Rodger and Stromshak (1986)
and Martin et al. (1990). Although the differences in concentrations were so small
that statistical significance could not be reached, the similarity of the findings
shows that GnRH given during metoestrus can cause a reduction in P4 production
after about one week. Martin et al. (1990) suggests that LH secreted in response
to GnRH acts on the CL to promote the conversion of small luteal cells to large
cells, which could explain alterations in P4 production. Although follicular growth
was not followed in the present study, it is obvious that the normal pattern of
follicular growth was likely perturbed by GnRH administration, and thus, the rise
in oestradiol concentration was delayed. Also this may have some effects on the
development and function of corpora lutea.
Many known biological effects of GnRH are caused by LH release some hours
after GnRH release/administration (Chenault et al., 1990). In the present study,
the LH surge as a consequence of GnRH treatment was not measured. Lucy and
Stevenson (1986) and Rosenberg et al. (1991) have, however, shown that GnRH
administered after the spontaneous LH surge caused significantly lower LH
release than when it was administered before the spontaneous surge. This has
been explained either by the decrease in oestradiol production, which follows the
LH surge (Zolman et al., 1974; Kesner et al., 1981), or by the refractoriness of
pituitary cells to GnRH after the LH surge (Kesner et al., 1981). However, the
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GnRH-induced LH surge in the study of Rosenberg et al. (1991) did not differ
from the spontaneous LH surge. The time interval between the spontaneous and
GnRH-induced LH surge was not described. It can be estimated from the
experimental protocol that the interval was, in most cases, most probably less
than 24 h. In our experiment, the time interval from the spontaneous LH surge to
GnRH administration was 30 to 54 h in group T1 and 54 to 78 h in group T2.
Because of this, it is unlikely that a weak LH response to GnRH administration
after the spontaneous LH surge in our study can explain the non-altered P4
production.
It is recommended for practical use, based on the findings of Macmillan et al.
(1986), that GnRH should not be administered during at least the first 3 days after
ovulation. In the present study, exogenous GnRH given 0 to 48 hours after
ovulation had no influence on P4 concentrations during the subsequent oestrous
cycle or on the length of the cycle. The only significant effect was the slight
decrease in the size of CL. These findings are not relevant enough to explain the
reduced pregnancy rate after the GnRH treatment given 1 to 3 days after
insemination, as reported by Macmillan et al. (1986). However, considering
previous and present results, administration of GnRH after ovulation should be
avoided.
7. Short oestrous cycles and PGF2α secretion
Peaks of 15-ketodihydro-PGF2α were identified by using the skewness method
described by Zarco et al. (1984). In this method, concentrations greater than 2SD
(Bekana et al, 1996; Kask, 1999; Königsson, 2001) or 3SD (Zarco et al., 1984;
Albihn et al., 1991) above the mean are arbitrarily considered to represent a
significant elevation. It is, however, possible that the use of 3SD may eliminate
some peaks that represent a significant synthesis and release of PGF2α. On the
other hand, the use of 2SD may find some “peaks” whose significance is
questionable. Considering the relatively short half-life of 15-ketodihydro-PGF2α
in the circulation of about 8 min (Kindahl et al., 1976a), the sampling interval of
3 h used in the present study is rather infrequent. Little can therefore be said
about the magnitude of the peaks, and the values that just barely reach the level of
significance may represent, in reality, much higher peaks. Because of this, 2SD
was selected to represent a significant elevation in the present study.
In the heifers showing a short oestrous cycle (group TS), frequent fluctuation with
4 to 7 peaks of 15-ketodihydro-PGF2α was observed during the period of high P4
(>3 nmol/l). The intervals between the pulses usually varied from 6 to 15 hours,
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but the intervals between the first 2 or 3 peaks tended to be somewhat longer,
concurring with the findings of Basu and Kindahl (1987) and Albihn et al. (1991)
obtained during spontaneous luteolysis. These fluctuations coincided with a
decrease in P4 concentration, indicating premature luteolysis. The manner of
fluctuations, duration, number of peaks, and intervals between peaks are
consistent with the findings obtained during spontaneous luteolysis in many
studies (Kindahl et al., 1976a; Kindahl et al., 1976b; Basu and Kindahl, 1987;
Albihn et al., 1991). The onset of this frequent pulsatility occurred 75 to 151 h
after ovulation. However, the first peaks in heifers 228 and 235 were so low that
it remains questionable whether these represent a significant release of PGF2α (see
the former paragraph). If these peaks are excluded, the onset occurred 96 to 151 h
after ovulation. In heifers with an oestrous cycle of normal length, either no or
only single peaks of 15-ketodihydro-PGF2α were observed during the period of
high P4. No frequent fluctuation similar to that in heifers showing a short oestrous
cycle was observed.
In heifer 225 (Table 8, Figure 4), the duration of the pulsatile pattern of 15-
ketodihydro-PGF2α concentration was divergently long, for at least 6 days (the
pulsatility possibly continued after the end of the sampling period), as compared
with the durations of the other heifers with a short oestrous cycle and durations
seen during spontaneous luteolysis in other studies, often a period of 2 to 3 days
(Kindahl et al., 1981). In this heifer, the rise in P4 concentration ceased and the
level was more or less unchanged, between 5 and 8 nmol/l, for 4 days, followed
by a sudden decline. The cessation coincided with the first peaks of 15-
ketodihydro-PGF2α. The pulses in 15-ketodihydro-PGF2α continued during the
period of stable P4 concentrations. This accords well with findings in which the
duration of the prostaglandin release continued for as long as the P4 concentration
was maintained at approximately 3.8 nmol/l by the P4 implants (Kindahl et al.,
1979; Kindahl et al., 1980). In this heifer, total responsiveness of the CL to PGF2α
may not have been achieved during the first days of PGF2α secretion, and thus, the
secretion continued at least until completion of luteolysis. However, the
pulsatility in 15-ketodihydro-PGF2α finished after a normal period of 2 to 3 days
in two other heifers (226 and 941), although P4 concentration remained at a
suprabasal level, around 2 and 3 nmol/l, after the luteolysis. Possibly, the P4
concentration of 3 nmol/l is close to a threshold level for PGF2α secretion.
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8. Oestrous signs during PG-induced oestrus with or without GnRH-induced
ovulation
To our knowledge, no studies have been published on the intensity of external
oestrous signs after PG treatments. However, many farmers believe that this
treatment is followed by weak oestrous signs. This does not seem to be true
according to our findings. The many studies show an enormous variation in the
incidence of metoestral bleeding: from 0.93% (Quayam and Austin, 1983) to “in
nearly all cows” (Youngquist, 1997). In practice, there seems to be a great deal of
variation among herds. Although some of this variation can be explained by the
variation in intensity of oestrous detection, real differences probably exist.
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CONCLUSIONS
Prematurely induced ovulation with GnRH treatment, at least when
performed after PG-induced luteolysis, causes shortened luteal function,
and thus, a short oestrous cycle, in some animals, either cows or heifers,
in both field and controlled study conditions. This phenomenon was
detected when the PG and GnRH treatments were given 24 hours apart,
and the PG treatment was given during the dominant phase of the first
follicular wave. This disturbance may lead to reduced fertility, as was
observed in some earlier studies.
We have demonstrated that the luteal regression seen in short oestrous
cycles induced with cloprostenol and GnRH 24 h apart in normal cycling
dairy heifers is related to premature release of PGF2α. This release closely
resembles the release of PGF2α during normal spontaneous luteolysis.
In heifers with a short oestrous cycle, no disturbances or changes in the
growth of the ovulatory follicle and ovulation preceding premature
luteolysis, or in the growth of the CL and the dominant follicle of the first
follicular wave of the short oestrous cycle could be detected, as compared
to heifers with an oestrous cycle of normal length. However, early
induction of ovulation with GnRH, 24 hours after PG treatment may have
affected the subsequent growth of the first follicular wave in both groups
of heifers with a short or a normal oestrous cycle. The follicle exceeded 6
mm one day earlier than in controls, which probably means that
recruitment had occurred earlier in relation to ovulation, or that the
follicle had been larger at recruitment. This difference remained almost
unchanged during the growth phase.
Exogenous GnRH given 0 to 48 hours after ovulation had no influence on
P4 concentrations during the subsequent oestrous cycle, nor on the length
of the cycle. The only significant effect was a slight decrease in the size
of the CL. These findings are unlikely to explain the reduced pregnancy
rate after the GnRH treatment given 1 to 3 days after insemination, as
reported elsewhere.
PG treatment did not seem to have any effect either on the intensity of
behavioural oestrous signs or metoestrous bleeding. GnRH treatment 24 h
after PG treatment weakened the oestrous signs significantly.
•
•
•
•
•
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The oestrus synchronisation effect of PG on day 6, and perhaps also on
day 7, after oestrus, may be poor, not only in cows, which has been
clearly demonstrated, but also in heifers.
•
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